Strategies to Expand the U.S. Automated External Defibrillator Market by Cervantes, Arturo
Walden University
ScholarWorks
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral StudiesCollection
2017
Strategies to Expand the U.S. Automated External
Defibrillator Market
Arturo Cervantes
Walden University
Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Business Administration, Management, and Operations Commons, Entrepreneurial
and Small Business Operations Commons, and the Management Sciences and Quantitative Methods
Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.
  
Walden University 
 
 
 
College of Management and Technology 
 
 
 
 
This is to certify that the doctoral study by 
 
 
Arturo Cervantes 
 
 
has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  
the review committee have been made. 
 
 
Review Committee 
Dr. Michael Ewald, Committee Chairperson, Doctor of Business Administration Faculty 
 
Dr. Kelly Chermack, Committee Member, Doctor of Business Administration Faculty 
 
Dr. Judith Blando, University Reviewer, Doctor of Business Administration Faculty 
 
 
 
 
 
Chief Academic Officer 
Eric Riedel, Ph.D. 
 
 
 
Walden University 
2017 
 
 
 
  
Abstract 
Strategies to Expand the U.S. Automated External Defibrillator Market 
by 
Arturo Cervantes 
 
MBA, Walden University 2009 
BA, The University of Texas at El Paso, 1976 
 
 
Proposal Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Business Administration 
 
 
Walden University 
April 2017 
  
Abstract 
Despite defibrillation as the only effective treatment for sudden cardiac arrest (SCA), less 
than 15% of homes and public facilities have access to an automated external defibrillator 
(AED). In the United States, ineffective response to SCA cases occurring each year 
classifies it as a business problem for medical device manufacturing leaders, emergency 
responders, and bystanders. The purpose of this multicase study was to explore the 
marketing strategies AED manufacturing leaders use to expand their consumer customer 
base. Data were collected via in-depth interviews from a purposive sample of participants 
from 2 U.S. AED manufacturers on the east coast, 2 AED distributors, and 2 healthcare 
corporations in Texas, as well as a review of company materials. The framework for this 
study was product life cycle theory. Initial findings for expanding the U.S. AED market 
indicated that the market was not led by its manufacturers but by its distributors. This 
finding became an important theme noted from AED manufacturers in considering the 
consumer segment, an aftermarket from commercial marketing strategies. A common 
concern for the security of strategic marketing was evident across the AED manufacturer 
participants with reluctance to discuss business models and marketing plans. A congruent 
theme was the curtailment of open discussions regarding AED marketing strategies 
because of security and confidentiality risk. Also limited number of approved AED 
manufacturers by the Federal Drug Administration minimizes AED access. Residual 
outcomes include improving the quality of life for the aging population while reducing 
the loss of the lives and costs of healthcare. Social implications include preventing 
sudden cardiac death by providing more accessibility of AEDs to baby boomers.  
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Section 1: Foundation of the Study  
The rising awareness of sudden cardiac arrest (SCA) and defibrillation in the 
United States are contributing to the growth of the defibrillator market. Sales of 
automated external defibrillators (AED) are increasing as part of patient monitoring 
service programs (Frost & Sullivan, 2012). Other contributors to the increase of 
awareness include more distribution of information and knowledge ascertained by the 
public of their effectiveness during critical minutes of resuscitation (AHA, 2014). The 
study includes exploring outcomes of public awareness and distribution of information 
regarding SCA. 
 In February of 2015, market researchers from Frost and Sullivan, Vision Gain, 
and Transparency, reported on the North American AED market. These market 
researchers estimated the market to grow at a compound annual growth rate (CAGR) of 
6.8% from 2014 to 2019 in the prevention of SCD. Furthermore, the same researchers 
concluded the United States continued to have a larger share of the AED market with 
about 85% in 2013 (Frost & Sullivan, 2012). In North America, the top seven 
manufacturers in the external defibrillator market control approximately 89.9% of the 
market. Of the seven manufacturers, three are U.S.-based companies controlling 85% of 
the market (Frost & Sullivan, 2012). The three manufacturers are Pseudo AED U.S., 
Pseudo2 AED U.S., and Pseudo3 AED U.S. 
The rising incidences of cardiovascular diseases (CVD) and SCA have various 
root causes. These causes include obesity, smoking, lack of exercise, and other heart 
diseases contribute to the increasing awareness of SCA and the life-saving potential of 
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AEDs (Heidenreich, Trogdon, & Khavjou, 2011). Businesses and individuals are 
recognizing the value of acquiring an AED and the importance of its accessibility through 
personal experience and published information from such sources as the American Heart 
Association (AHA).  
Governance and federal compliances are a component of AED manufacturing and 
its public access. The AHA as well as state legislation such as the District of Columbia, 
have public access defibrillation statutes and regulations in effect in 51 U.S. Jurisdictions 
(Gilchrist et al., 2012). They advocate the installation of AEDs for public access, what is 
referred to as a public access defibrillator (PAD). Government campaigns, media 
coverage, Internet articles, and word of mouth, are some of the driving factors for market 
growth in small, medium, and large businesses as well as consumer markets. 
The AHA (2014) determined that the survival rate of those treated with an AED, 
coupled with cardiopulmonary resuscitation (CPR), nearly doubles those treated with 
CPR alone. Timely application and general understanding of the AED by the user or 
bystander will yield a higher chance of survival (Yeung, Okamoto, Soar, & Perkins, 
2011). Therefore, accessibility to an AED and bystander training during SCA incidents 
increases the chance of a victim’s survival. 
Growing direct sales channels and distributor network expansion by AED 
manufacturers are posting gains in the emerging U.S. commercial market segment.  
The top three AED manufacturers sold more AEDs to the commercial and consumer 
sector between 2013 and 2014 than any other year prior. Sales to corporate workplaces 
and public facilities have surged based on the growing demand and account for more than 
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40% of leading manufacturers’ domestic AED revenue (Frost & Sullivan, 2012). U.S. 
medical device manufacturers’ AED sales grew at a rate of approximately 70% 
(Heidenreich, Trogdon, & Khavjou, 2011). This percent is more than twice the rate of 
growth of the worldwide AED market. Market revenue for 2010 was $547.4 million and 
reaching $803.9 million in 2016 (Frost & Sullivan, 2011). While this is a substantial 
ground trend, AED sales are targeted to the business and public facilities markets. 
Defibrillation is the only treatment for SCA victims during life-threatening 
cardiac arrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia (Go et 
al., 2014). Automated external defibrillators provide an electrical shock terminating the 
arrhythmia and restoring the normal rhythm in the heart. Defibrillator devices are useful 
and the only means of preventing deaths during SCA (Go et al., 2014) for patients with 
unknown heart conditions. The number of SCA incidents continues to increase year over 
year.  
The baby boomer population is aging in the United States alongside the rising 
cases of hypertension among adults 65 years and older. As more Americans continue 
smoking cigarettes, ingesting a poor diet, and curtailing their physical exercise, SCA 
numbers will trend upward (AHA, 2013). Because of these contributors and 
cardiovascular diseases, they become the major drivers of AED market growth. If 
medical device manufacturing and distribution marketing leaders design and execute 
marketing strategies and plans timely and effectively, they may position themselves for 
future growth in the customer base.  
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There are considerable costs associated with CVD. The direct and indirect cost of 
CVD and strokes in the United States for 2014 is $315 billion (Go et al., 2014). Coronary 
heart disease (CHD), in the United States alone, is costing $108 billion each year 
(Heidenreich et al., 2011). Coronary heart disease took one of every six lives in 2010. Per 
the AHA (2013), an estimated 620,000 Americans have a new coronary attack annually. 
A coronary attack is a first hospitalized myocardial infarction with 295,000 developing a 
recurring attack annually. The AHA (2013) estimated an additional 150,000 silent first 
myocardial infarctions occur each year. Every 34 seconds one American has a coronary 
event (Go et al., 2014). Every minute seven seconds one American dies of a myocardial 
infarction and nearly 400,000 out-of-hospital sudden cardiac arrests occur annually 
(AHA, 2014). Many deaths from CVD impact both the direct and indirect costs of caring 
for stroke and post SCA victims. 
The U.S. Department of Health & Human Services (HHS) has a very honorable 
mission. Its priorities are based on enhancing and protecting the health and well-being of 
all Americans. Statistics from both the AHA and the U.S. Department of Health and 
Human Services confirm more than 900 deaths to sudden cardiac arrest each day 
(USDHHS, 2013). Public Access Defibrillation (PAD) programs, AED Programs for 
businesses, and other community-based chain-of-survival initiatives (Fothergill et al., 
2013) assist SCA victims. Given the growth continuum in sudden cardiac death (SCD), 
there is a need for more aggressive marketing campaigns by medical device manufacturer 
marketing leaders to capture the commercial and consumer AED market. The goal of this 
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study was to explore strategic opportunities for medical device manufacturing company 
leaders to expand their AED customer base. 
Background of the Problem 
Having access to an AED anywhere is as important as the ability to apply it to 
prevent sudden cardiac death (SCD). The United States is the largest market for 
defibrillator devices and expecting to retain its top position through 2019. 
Notwithstanding its market position, approximately 350,000 Americans lives are lost 
annually to sudden cardiac arrest with 88% of all SCAs in the United States occurring at 
home and public facilities (AHA, 2013). Cardio Vascular Disease and stroke in the 
United States account for more than 930,000 deaths per year. The estimated cost is $315 
billion (Go et al., 2014). The lack of AED programs and accessibility to public facilities, 
workplace, and homes is contributing to a $108 billion expense each year (Heidenreich et 
al., 2011). As a result of this large expense on SCA, medical device manufacturers’ AED 
sales grew at a rate of approximately 70% (Heidenreich et al., 2011). This rate is more 
than twice the growth of the worldwide AED market. Despite this rate of growth, less 
than 34% of United States has public access to an AED, and less than 15% of private 
facilities have an AED (AHA, 2012). The AHA has previously addressed potential 
preventive initiatives for out-of-hospital SCA by way of CPR and defibrillation; Public 
Access Defibrillation (PAD); and bystander training.  
In this study, I explored whether device manufacturing and distribution marketing 
leaders are maximizing their strategies on the AED customer base growth or leaving 
expansion opportunities in the U.S. home and public settings untapped. In addition, this 
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research includes consumer AED market opportunities, which are based on SCA statistics 
that indicate growth. In this study, I addressed research questions to the problem and 
discuss the business and social change implications of this research. 
Problem Statement 
Defibrillation is the only effective treatment for sudden cardiac arrest, yet less 
than 15% of public facilities and homes have an AED (Go et al., 2014). Medical device 
manufacturing and distribution marketing leaders are leaving an 85% potential market in 
the consumer segment unequipped (AHA, 2012). The general business problem is that 
some medical device manufacturing and distribution marketing leaders are not 
maximizing their sales potential in the U.S. consumer AED markets. The specific 
business problem is that some medical device manufacturing leaders have limited 
marketing strategies to expand their AED consumer base in the United States. 
Purpose Statement 
The purpose of this multicase study was to explore the marketing strategies 
medical device manufacturing company leaders use to expand their consumer customer 
base. The research method is qualitative with a multicase study as the research design. 
The population included medical device manufacturing marketing professionals from the 
top 3 U.S. companies, its distributors, and healthcare professionals. During the research 
and interviews, it was determined that while they were aware that the consumer base was 
expanding, their marketing strategies were not focused on this space.  
A qualitative multicase study is a valuable method for research to develop theory, 
evaluate programs, and develop interventions (Baxter & Jack, 2008). The subset of the 
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sample was the company’s consumer goods division responsible for the U.S. market. 
Expected outcomes of the research include convincing corporate leaders of their potential 
and financial gain. The sample may also contribute to business growth in the medical 
device industry and assist in reducing the $100 billion in annual expense for U.S. 
consumers (Heidenreich et al., 2011). As part of social change, the use of AEDs may 
prevent the loss of the lives of more than 350,000 SCA victims dying annually of which 
88% are occurring at home and within public settings (AHA, 2013).  
Nature of the Study 
For this study, I used a qualitative, multicase study. The method identifies 
business issues across the population and not from a hypothesis (see Yin, 2013). As a 
form of inductive research, the qualitative approach was appropriate. This multicase 
includes medical device manufacturing company leaders and marketing professionals 
from various companies and healthcare professionals. The case study design assisted in 
my understanding of what marketing strategies managers use to grow their customer 
base. This qualitative case study and its design contributed toward a proposed solution for 
the business problem. The rationale behind the leader selection was to identify strategic 
decision makers and change agents from the manufacturing and companies. By 
identifying participants from the marketing, sales, medical, and technology organization, 
my expectation was to be then able to cultivate specific data from each with in-depth 
interviews.  
The qualitative research method was appropriate for this study. Because my 
interest as a researcher was to secure reliable observations and gathering primarily verbal 
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data rather than measurements, I chose the qualitative method over quantitative and 
mixed methods. I also chose it because of the personal nature of this approach (Ritchie, 
Lewis, Nicholls, & Ormston, 2013). Qualitative approaches to information gathering 
focus on why and how questions and involve direct interaction with individuals in a one-
on-one or group setting, whereas quantitative approaches focus on relationships between 
variables (Silverman, (2013). Research which typically involves counting and classifying 
as its attributes, is quantitative in nature. The Mixed Method Research blends both 
qualitative and quantitative attributes and approaches.  
A case study was more appropriate for this research than phenomenology, 
narrative, grounded theory, or ethnographic design. A case study allows the researcher to 
conduct an in-depth investigation of a single individual, group, or event. During the 
exploratory research, it became evident that several individuals from different business 
groups would be needed. A multicase study design with the qualitative approach was 
determined to be the most appropriate design for this study. The research method 
determined the planning and strategy points. In-depth interviews were the most 
appropriate for collecting data on naturally occurring behaviors in their usual contexts. 
In-depth interviews were one method of data collection used in this study (Muskat, 
Blackman, & Muskat, 2012). In contrast, ethnographic is wider in scope and focuses on 
the sociology of meaning through close field observations of sociocultural phenomena. 
Phenomenology was also not appropriate for this study because it delineates itself from 
any recourse to theory, deduction, or assumptions from other disciplines. Grounded 
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Theory was also not a good fit because it focuses on research to understand the social and 
psychological processes that describes an event or situation (Marshall & Rossman, 2014). 
Research Question 
The research question for this study was: What marketing strategies medical 
device manufacturing company leaders use to expand their U.S. consumer customer 
base? 
Interview Questions 
1. Would you describe how your company’s business model is open to 
partnerships that promote innovation? 
2. How does the U.S. automated defibrillator market compare to others in the 
world? 
3. How has your AED distributor network model evolved over the last few 
years? 
4. How far are we from having an AED in every home? 
5. How will first responder services be affected in case of SCA with hospitals 
moving from rural to metropolitan areas? 
6. How is product affordability of AEDs for the aging senior consumer being 
addressed by your company? 
7. Would you describe your company’s perspective of AED Training Programs 
as a product value-add for market growth?  
8. How have AED recalls influenced your product design? 
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9. Despite public awareness of CVD and large market share of AED sales in the 
United States, why does CVD still account for over 340,000 deaths outside of 
healthcare settings each year? 
10.  Would you elaborate on your company’s involvement in medical device 
solutions for hospital treatment post-SCA? 
Conceptual Framework 
The conceptual framework for this study was the product life cycle (PLC) 
theory.  The PLC theory pursues the notion of a product’s market presence is like 
organic life (Nadeaua & Casselmanb, 2008). The four life stages of a PLC in which a 
product passes through are from inception to death. These four life stages include an 
introduction, growth, maturity, and decline which distinctively share more market 
characteristics with other products in the same stage than with itself at a previous or later 
stage. Per Michael Grieves (1971), these stages are where a product perish and become 
petrified. When infused onto organizational marketing strategies, PLC provides useful 
insight into competitive tactics, an alternate perspective on how to address issues of 
supply and demand, as well as those of time (Nadeaua & Casselmanb, 2008).  
People manage organizations. Their influence and the decision-making culture 
they created come from their behaviors. In 1928, Marston wrote in the book, Emotions 
of Normal People, about how human behavior is not so cut-and-dry or black and white 
(Marston & Moulton, 2013). The author then went on to describe the various types of 
behaviors. While he did not write the Drive Influence Steadiness Compliance (DISC) 
theory of personality styles, his concepts behind DISC are the framework of the theory. 
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The theory later influenced the development of the actual DISC test (Marston, King, & 
Marston, 1999). The decision-making culture of the participants was explored. 
Dominance styles are typically early adaptors and leaders driving the first-to-
market culture in their respective organizations (Nadeaua & Casselmanb, 2008). The 
problem-solving process for medical device manufacturers in the United States requires a 
dominant approach by its marketing leaders to PLC. The dominant approach contributes 
to growing their consumer customer base. The Product Life Cycle may augment open 
business models. New business models allow outside ideas and technologies to be 
infused and propagate onto their products and services. The infusion may augment their 
economic potential (Chesbrough, 2012). 
Definition of Terms 
The operational definitions listed below are of technical terms, jargon, or special 
words, in alphabetical order. Also listed are citations of definitions from peer-reviewed 
articles/government websites. 
Automated external defibrillator (AED): An AED is a computerized medical 
device which can check a person’s heart as well as a potential shock it back to a normal 
rhythm (AHA, 2014). 
Boomer: The word boomer refers to the Baby Boomer population of those born 
between 1946 through 1964. This generation is the Boomer Generation and portrayed as 
a generation of optimism, exploration, and achievement with increased educational, 
financial and social opportunities (Fingerman, Pillemer, Silverstein, & Suitor, 2012).   
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Cloud computing: Cloud computing is the use of powerful computing hardware 
for processing and leveraging high-speed Internet and software in smart mobile devices 
to gain ease of application management and ubiquity (Armbrust et al., 2010).  
eHealth: eHealth (also written e-health) is a term for healthcare practice 
supported by electronic processes and communication, dating back to at least 1999. 
Industry leaders and marketing personnel use this term rather than academicians. The use 
of the term is in line with other e-words such as e-commerce, e-business, e-solutions, in 
an attempt to convey the promises, principles, the excitement around e-commerce 
(electronic commerce) to the health arena. The term’s use is to account for the new 
possibilities the Internet is opening to the area of healthcare (Fox & Duggan, 2012).   
mHealth Technology: Mobile healthcare technology is the same as mHealth. The 
use of mobile devices for health-related behaviors and human metrics (Brown, Yen, 
Rojas, & Schnall, 2013) is mHealth Technology. Health Informatics is MHealth 
Technology. This technology is used as a survey on ambient-assisted living tools for 
older adults (Rashidi & Mihailidis, (2013). 
Myocardial infarction: Necrosis or destruction of a region of the myocardium 
caused by an interruption in the supply of blood to the heart is usually because of 
occlusion of a coronary artery.  A myocardial infarction is a cardiac infarction (Meier et 
al., 2013). 
Smarthome: Smarthome is the term used to describe a home built with technology 
infrastructure. The infrastructure may include telecommunication transport connectivity 
with wide broadband capacity. It may also include Ethernet wiring and power sources as 
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a premise to add technological applications. Telemedicine is one application used to 
monitor patients’ vitals at home (Li, 2013). Voice communication and automated voice 
recognition applications on devices, will present a system of vocal order recognition in 
distant speech context. These features benefit the disabled and aging community at home 
(Portet, Vacher, Golanski, Roux, & Meillon, 2013). 
Spoofing: Spoofing is the creation of TCP/IP packets using someone else’s IP 
address. Routers use the destination IP address to forward packets through the Internet 
but ignore the source IP address. The destination machine uses the address to respond to 
the source (Jafarnia-Jahromi, Broumandan, Nielsen, & Lachapelle, 2012). 
Sudden cardiac arrest (SCA): Cardiac arrest, also known as sudden cardiac arrest,  
is the abrupt loss of heart function in a person who may or may not have diagnosed heart 
disease (AHA, 2014). 
Ventricular fibrillation (VF): VF is an arrhythmia most commonly associated 
with the onset of Sudden Cardiac Arrest (AHA, 2014). 
Assumptions, Limitations, and Delimitations 
Assumptions 
An assumption is a supposition taken by a researcher as truth without actual 
verification or valid reference. Assumptions may carry risk in this study (Silverman, 
2013). My first assumption was that the qualitative approach was the most appropriate 
method to explore the related factor. I also assumed that my selection of a multicase 
study design was an appropriate one for this study. Another assumption was the 
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participants selected would participate and provide honest responses (see Denzin & 
Lincoln, 2011).  
  In this study, I also assumed that, despite sales growth of AEDs, medical device 
manufacturing leaders are failing to equip the U.S. consumer markets proportionally and 
were contributing to slowing down the continued growth of SCD. Sudden cardiac arrest 
continues to be the number one killer of all combined deaths in America year over year. 
The assumption was that medical device manufacturer marketing leaders are not aware of 
the untapped emerging markets. Another assumption included the possibility that out-of-
hospital defibrillator sales opportunities to the 65-year-old plus boomer population were 
the most abundant market for growth in the consumer space.  
The assumptions of this study also included some medical device manufacturing 
and distribution marketing leaders not maximizing their market potential of their 
consumer goods and have limited marketing strategies to expand their AED customer 
base. Included in this study was a correlation between the high percent of U.S. homes and 
public settings unequipped with an AED and the 88% of SCAs occurring in American 
homes (AHA, 2012). The lack of AED sales to the U.S. homeowner will increase as more 
of the retiring boomer population grows and ages, proving all assumptions to be true.  
Limitations 
A limitation is a limiting condition and restrictive weakness. A limitation also 
lacks in capacity and the inability of the study (Locke, Spirduso, & Silverman, 2013). 
Several limitations existed in this study. The first included the number of available 
medical device manufacturers approved by the FDA of home AED models available for 
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sale without a medical doctor’s prescription (Lenzer, 2004). The limitation is one 
manufacturer spanning 2 decades through 2010. In 2013, two other AED manufacturers 
were approved by the FDA, yet lack the manufacturing tenure of the top two 
manufacturers. Also, because medical device manufacturing and distribution marketing 
leaders have experienced high percentages of sales growth, they were, to an extent, 
myopic to the 85% marketing opportunity in the consumer goods sector. The 85% is the 
market growth remaining in the customer base citation?.  
Medical device manufacturing and distribution marketing leaders determined their 
sizeable sales growth (Frost & Sullivan, 2012) as effective outcomes of their marketing 
strategies. Their sizeable sales growth, as the total potential for growth, may continue to 
be a misperception and prevent them from an open consideration of new marketing 
strategies. By not seeking to expand onto existing or emerging markets, a sales limitation 
continues to occur. The assumed limitation that the prospective manufacturer marketing 
leaders and its distributors, which are of European culture and business acumen, curtailed 
open business models to be infused was confirmed. Their marketing strategies do not 
allow infusing an open business model (Chesbrough, 2012). Marketing leaders continue 
to decide not to leverage the product life cycle onto their organizational marketing 
strategies to provide useful insight into competitive tactics (Nadeaua & Casselmanb, 
2008).  Using direct sales channels for the consumer market is where their ideology 
varied and their approach to market penetration, pricing, and retailers’ product sales 
management. In turn, distributors and sales channels are those entities with open sales 
models, partnerships, and innovative initiatives. 
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Delimitations 
Delimitations are boundaries that researchers impose to focus the scope of a study 
(Mitchell & Jolley, 2010). Some areas addressed include limited geographical location 
and a brief period to collect the data. Delimitations are within a researcher’s control. 
Delimiting factors occurring in the study include the choice of objectives, the research 
questions, variables of interest, theoretical perspectives adopted by the researcher, and the 
population the researcher chooses to investigate (Simon, 2011). In using selected group 
of medical device manufacturing and distribution marketing leaders as a sample of 
convenience, as opposed to a random sample, delimited the choice of the population to 
investigate. The criteria in delimitating to a single firm were by leadership in U.S. market 
share in the consumer segment and approval by the FDA.  
By delimitating time and duration to conduct this study, I attempted to control the 
scope of the study related to emerging markets driven by new technology conditions. The 
scope changed to some degree in the interval of the study. In this awareness, the research 
reflected data from the period and time of the interviews, corporate website, and data 
assessment (Coutts & Jann, 2011).  
Significance of the Study 
Contribution to Business Practice  
There is a substantial business value in maximizing sales to U.S. consumers and 
emerging markets without AEDs or its bystander programs by the medical device 
manufacturers and its distribution channels in untapped markets. One of those untapped 
markets is the baby boomer retiree within the consumer market with only 15% having an 
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AED program (AHA, 2012). I explored potential marketing strategies to expand the 
untapped 85% AED consumer markets. The number of AEDs sales trends in the United 
States varies by researchers. Those researching AED trends from the largest medical 
device manufacturers worldwide estimated that in 2014, 775,000 units were sold annually 
to the public. These metrics represent an increase of approximately 30% per year 
(Markets & Markets, 2014). The market will reach $12.9 billion by 2019 at CAGR of 
6.9% from 2014 to 2019 or approximately 912,750 units (Markets & Markets, 2014). The 
forecast period of 2014 to 2019 is based on the metrics from studies of the global 
defibrillators market. My intended contribution from this study was to surface segments 
of the consumer market where AED has its greatest potential for growth. 
Based on this research, forecast dated as early as 2012 were already predicting 
annual revenue for the automated external defibrillator market by the end of 2015 to be 
$1.7 billion in the United States (Starr, 2012). The Global defibrillator market is expected 
to reach USD 15.75 billion by 2020 with a compound annual growth (CAGR) of 7.89 
percent over the period 2014-2019. The U.S. market share represented less than 1% 
(Heidenreich et al., 2011) in 2011, yet Grand View Research (Grand View Research, 
2015), forecasted to reach 10.7 percent share by 2020. This statistic supports the 
fundamental business problem and the opportunity to increase U.S. market share within 
the AED commercial and consumer goods by medical device manufacturer marketing 
leaders with marketing strategies contributing to effective business practices. 
Derivatives and findings from this study may influence manufacturing and 
distribution marketing leaders to shift their marketing and sales strategies more 
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effectively. Marketing leaders’ existing strategies, for most manufacturers in the United 
States, include sustaining 70% annual sales growth (Frost & Sullivan, 2011) in the 
existing markets, rather than exploring new marketing strategies and emerging markets in 
consumer goods of medical devices. Since the beginning of this study, new strategies 
have surfaced and will potentially represent a multibillion-dollar uplift in sales. Pseudo 
AED U.S., April 5, 2016, news release supports the AHA recommendations for wearable 
defibrillator use for the prevention of sudden cardiac death, is one example. 
New product development and sales initiatives would accomplish what other 
researchers have not in this area of business. Other researchers have not explored 
emerging markets in the home and public settings, related to mHealth technologies. Other 
exploration for market growth opportunities may include the aging population from the 
U.S. baby boomers’ era. This shift of focus and paradigm on manufacturing and 
distribution marketing leaders will bring meaningful insight and influence new strategies 
and customer base growth to medical device manufacturing companies marketing in the 
United States. 
Implications for Social Change 
The principle contribution toward positive change is to make a substantial 
advancement toward the improvement of human conditions. The improvement is by 
promoting AED programs for public access, home healthcare, out-of-hospital, and 
cardiac monitoring to prevent the loss of lives to SCA. The objective was to uncover 
AED manufacturer marketing strategies and its distribution channels that may yield just-
in-time AED access and bystander assistance in the first four minutes a victim suffers 
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heart failure. Other authors and medical community leaders have addressed prevention by 
Emergency Medical Service (EMS) dispatching (Go et al., 2014), and other measures for 
cardiovascular disease.  These measures include dieting, exercising, stress management, 
reduced tobacco consumption, and surgical procedures of Implantable cardioverter-
defibrillators (Roger, Go, Lloyd-Jones, & Benjamin, 2012). While these measures 
contribute to the prevention of CVD, none addresses the prevention of SCD in the critical 
first 4 minutes that SCA occurs in a victim.  
The true business application of this current study is to pivot the attention and 
resources toward solutions with timely responsiveness to the home and public AED 
programs during SCA. Social solutions or medical research of the root causes of coronary 
heart disease are more applicable to future cases and not for life-threatening solutions. 
Preventive medicine for individuals and organizational leadership will have a paradigm 
and ideology shift that will facilitate an opportunity for each to invoke positive change. 
The principle effect of the positive change is to make a substantial contribution toward 
the reduction of SCD victims and associated healthcare costs while contributing to the 
individual quality of life (Greengard, 2013).  This paradigm shift and new awareness will 
help strengthen leadership accountability and innovation for reducing SCD and cost of 
healthcare in the United States.  
A Review of the Professional and Academic Literature 
The purpose of this literature review was to provide an overview of relevant, 
current, and previous studies, as well as a critical analysis and synthesis of various 
sources with a depth of inquiry. A critical analysis and depth of inquiry include the 
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increasing number of retiring and aging baby boomers to their homes and rural areas 
coupled with their increasing needs for medical services. The purpose of the analysis is to 
address issues surrounding the U.S. AED consumer market and its vast potential. This 
review includes an in-depth analysis of the trends in healthcare with the demands for 
hospitals to consolidate their presence and resources. The consolidation includes 
hospitals moving from rural areas to metropolitan areas in rendering medical services to 
the growing aging population.   
The study includes a discussion of how this issue may create more market 
opportunity and AED manufacturers’ marketing position. Included in the review will be 
the product life cycle (PLC) theory. The theory pursues the notion of a product’s market 
presence is similar to organic life use of a dominance leadership style. In the review, I 
also addressed the rising cost of healthcare and the effect AED manufacturers potentially 
have in its reduction. Other issues and potential marketing opportunities are part of this 
review. The inclusion is specific to the dependency of accessibility and immediate 
medical attention and its relation to AEDs with the knowledge that 88% of SCAs happen 
at home and public areas. AEDs are an essential tool to restarting the heart and placement 
to cover the greatest amount of area and is the responsibility of the medical device 
manufacturers to provide approved models for home use. Automated External 
Defibrillator manufacturer sales and distribution of their AEDs to the consumer market is 
only 15% by all companies combined. There is an opportunity to explore the theory of 
the misalignment in their market strategies and demand in new markets. As a result, there 
is a curtailment of their business and social responsibilities. In this case study, I explored 
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AED coverage in out-of-hospital settings to determine its current and growing 
contribution to a $108 billion expense each year.  
 This literature review consists of scholarly and medical journals covering broad 
issues related to marketing and sales outcomes of AEDs by medical device 
manufacturers. Also included in the review are scholarly journals regarding strategic 
marketing for AED customer base growth in the United States. This review also consisted 
of trends in healthcare pertinent to demands forced on hospitals to consulate their 
presence and resources in metropolitan areas as opposed to remote or rural areas 
alongside associated industry issues. The literature review has content of trends and 
forecasts from medical journal literature on the baby boomer population, the aging, and 
its correlation with hypertension cases on the rise. The cases are among adults 65 years or 
older and the upward trend of SCA.  
Governance by the FDA and state governments was part of the review exploring 
the contributing factors to bystander and training reticence. I also discussed research 
regarding the FDA governance and recall compliance as well as over-the-counter 
purchases and physician’s prescription. Last, the literature review includes open business 
models, emerging technologies, and public awareness of AED programs.  
I created this critical analysis and synthesis of various sources and content found 
in journals, reports, and scholarly books mainly through Walden Library of business 
management and technology professionals. I also used United States government 
regulatory entities published documents and other scholarly resources. Databases 
searched were: Business Source Complete, Lexis Nexus Academics, and Google Scholar. 
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Search terms included: heart disease and stroke statistics, sudden cardiac arrest, life-
saving AEDs, bystander and CPR, randomized response techniques, baby boomer, 
Association of American Retired Persons (AARP), defibrillation, Cardiopulmonary 
Resuscitation (CPR), and emerging technologies.  
My strategy in searching the literature included a clear understanding of the 
general and specific business problem of the study. I identified the subject matters 
associated with business, marketing, healthcare, aging population, emerging 
technologies, and governance. Ensuring 85% total of peer-reviewed sources with a 
minimum of 60 peer-reviewed sources for this literature review meets rubric criteria. 
Also, that 85% of the total sources have a publication dated less than 5 years from the 
anticipated completion date of study. 
Within this doctoral study, there are 114 sources. Of the 114 sources, 107 or 
93.8% are peer-reviewed. Seventeen sources that are more than 5 years of their published 
date to the date of this study were included. The total sources 5 years of their published 
date leave 97 sources dated 5 years or less of publishing from the date of this study, or 
85.1%.  
 I have divided this literature review into five main subject categories. In the 
business and marketing management category, I explored the perceived causes of medical 
device manufacturing and distribution marketing leaders’ failures in maximizing their 
market potential. I also explored the possibility of lack of awareness and use of an open 
business model to allow outside ideas and technologies. The potential use of an open 
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business model and its propagation onto their products and services, augmenting their 
economic potential is a part of this review.  
 Last, I explored the past and current marketing strategies used to determine the 
potential need to develop sustainable marketing strategies to expand their AED customer 
base. In the healthcare and retirement trends of aging boomer population category, I 
explored each trend to uncover root causes and potential pressure on the medical device 
manufacturers to develop new marketing strategies in the consumer market of AED home 
unit solutions. In the emerging technologies in medical devices category, I explored the 
rising cost of healthcare attributed to SCA. In the final category, I explored security, 
safety, and governance of AEDs.  
Business and Marketing Management 
 PLC marketing with a dominance leadership style.  Product Life Cycle theory 
is the notion of a product’s market presence of a product is like organic life (Nadeaua & 
Casselmanb, 2008). The four life stages of a PLC in which a product passes through are 
from inception to death, where death is petrification (Michael, 1971). The four stages of 
PLC are an introduction, growth, maturity, and decline. These stages are distinct as they 
share more market characteristics with other products in the same stage than with a 
previous or later stage. When infused onto organizational marketing strategies, PLC 
provides useful insight into competitive tactics, an alternate perspective on how to 
address issues of supply and demand as well as those of time (Nadeaua & Casselmanb, 
2008). People manage organizations and their influence, and the decision-making culture 
they created are from their behaviors. Marston (1928) in the book Emotions of Normal 
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People, wrote about how human behavior is not so cut-and-dried or black and white. He 
went on to describe the various types of behaviors. While the author did not write the 
DISC theory of personality styles, the concepts behind are the framework of his theory 
and led to the theory of the later development of the actual DISC test. These styles 
include dominance, influence, steadiness, and compliance.  
 The theory and evaluation regarding those leaders with dominance as the primary 
style with a potential blend of the other personality types affect their everyday actions. 
These actions influence a culture in an organization (Nadeaua & Casselmanb, 2008). 
Dominance styles are typically early adaptors and leaders driving the first-to-market 
culture in their respective organizations (Nadeaua & Casselmanb, 2008). Given this 
marketing theory and its relativity to the business problem, medical device manufacturers 
in the United States will need to be open for a new business model. Manufacturers’  
marketing leaders must lead with a dominant approach to PLC to grow their consumer 
base. Leveraging PLC through marketing leaders will open opportunities to alter the 
competitive landscape (Nadeaua & Casselmanb, 2008). Leading with PLC will also open 
business models allowing outside ideas and technologies infused and propagated onto 
their products and services. These efforts assist leaders in augmenting their economic 
potential (Chesbrough, 2012).  
Based on the percentages of sales by these medical device manufacturers, sales of 
AEDs to the consumer market is only a 15% share of all companies combined.  With 
88% of SCAs occurring at home and public settings, combined with an 85% AED home 
market potential, the opportunity remains in applying the PLC marketing theory to solve 
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this business problem. The conceptual framework includes understanding the potential 
cause for the lack of some medical device manufacturing and distribution marketing 
leaders not maximizing their sales potential in the U.S. consumer AED markets. The 
framework also includes a conceptual element regarding the potential correlation between 
U.S. consumers and out-of-hospital facilities to AED programs. The correlation includes 
leaving U.S. consumers at home and other out-of-hospital facilities unequipped with 
AED programs. This void is an untapped market left open by AED manufacturer 
marketing leaders. By leaving this segment of the market open, it contributes to the 
increasing deaths associated with SCA and the financial effect on American businesses, 
its consumers, and their experience and sensory systems (Achrol & Kotler, 2012). 
 Marketing opportunities to expand the customer base. Publications from the 
AHA indicated that 88% of SCAs occur at home and in public settings (AHA, 2013). In 
the workplace,  3% occur, according to the U.S. Department of Labor – Occupational 
Safety & Health Administration (USDL-OSHA) records dating from 2003 to 2014. The 
remaining 9% occurring in other out-of-hospital locations. The marketing opportunity to 
expand the customer base is in the home consumer market. In the home is where 792 of 
the 932 daily deaths attributed to SCA in contrast to only 27 cases in the workplace with 
the remaining 81 cases in other out-of-hospital locations.  
 The Food and Drug Administration (FDA) has approved AEDs for home use 
without a prescription by four medical device manufacturers in 2013. Homes are the least 
equipped with AEDs or AED programs (Jorgenson et al., 2013) despite FDA approvals. 
One U.S. manufacturer with such approval occurred in 2010 (USDHHS, 2010). In 2013 a 
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second company received such approval and more throughout 2014. These FDA 
approvals, alongside the untapped potential customer base growth of the baby boomer 
consumer market, are evidence of a gap. This gap remains a considerably large marketing 
opportunity for medical device manufacturers. 
 Despite awareness of defibrillation being the only effective treatment for sudden 
cardiac arrest (Go et al., 2014) plans for a solution fail to exist. The AHA’s initiatives in 
SCD prevention and the sales growth of AEDs to corporations and homeowners in 
America falls short of the needed coverage. Less than 34% of the United States has 
public access to an AED, and less than 15% of private facilities have an AED (AHA, 
2012). With only 34% of public access to an AED, medical device manufacturing and 
distribution marketing leaders are leaving a 66% of the market unequipped. The results 
are similar for other consumers. The other consumers account for 85% of the U.S. 
market. Segments of this market are private facilities and homes do not own an AED. 
Trusted entities such as the AHA, AMA, Journal of Medicine, and by the medical device 
manufacturers, distribute public information of this nature.  
 The U.S. AED market opportunity for growth remains open. When compared to 
the global defibrillator market at $9.3 billion in 2012 (Frost & Sullivan, 2012), the 
percentage represents only a fraction of the global market. The expectation in the global 
market is growth at a compound annual growth rate (CAGR) of 6.2% from the year 2013 
to 2019. Transparency Market Research (2012) forecasted an estimated value of $14.2 
billion in 2019 North America, which includes the United States, Mexico, and Canada. 
This forecast represents the largest market for AED, followed by Japan and Europe. 
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North America and Japan forecasted to grow at a slower pace, primarily because of 
saturation in the market. The expectation in the Asian market is to register maximum 
growth over the next 5 years, based on the increasing installation of AEDs and rising 
prevalence of cardiovascular diseases. Market values between the United States, Canada, 
Mexico, Asia, and the globe may vary. As long as the potential of each respective market 
excludes the home model AED in their forecast, the U.S. market will hold its value. 
 The market for AED has become dynamic with companies in this segment 
adopting growth strategies of collaborations, agreements, and acquisitions. Emerging 
markets and out-of-hospital defibrillators represent abundant opportunities for 
stakeholders in this space. The AHA informed the public of decreasing survival rate. The 
public information illustrated decreasing survival rates to only 9.5% of the 359,400 out-
of-hospital cardiac arrest incidents in 2013 in the United States. This decrease accounts 
23.9% of adults and 40.2% for children in-hospital respectively for 209,000 incidents 
(AHA, 2012). These statistics includes African-Americans as they are almost twice as 
likely to experience cardiac arrest at home, work, or in another public location than 
Caucasians. African-Americans survival rates are half of Caucasians (AHA, 2013). 
African-Americans are much more likely to have diabetes, hypertension, a low 
educational level, low income, and lower mean levels of physical activity (Taylor Jr. et 
al., 2005). Women who are of Hispanic and African-American ethnicities are somewhat 
more likely than men to experience some of the other common symptoms particular 
shortness of breath, nausea/vomiting, and back or jaw pain. Symptoms as these are more 
difficult to determine while warning others that SCA is occurring (AHA, 2014).  
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 Implementing open business models for AED manufacturers. This multicase 
study was on multiple leading medical device manufacturers; AED distributors and 
healthcare professionals in the United States. The study includes exploring factors 
motivating marketing leaders from the leading medical device manufacturers to seek 
assistance from experts to help develop more sustainable marketing strategies. These 
factors may include infusing an open business model. This portion of the literature review 
includes a discussion of the importance for medical device manufacturers to be in 
knowledge of the magnitude of the AED marketing opportunity. Although the big three 
U.S. manufacturers are augmenting their AED production, the question remains if they 
are effective in targeting the consumer segment and use of marketing strategies. The 
tendency of U.S. manufacturers to have proprietary business models and resident 
intellectual property is symptomatic and inherent to the manufacturing industry. These 
business models strengthen the company’s market share with their own patented 
products. Automated External Defibrillator manufacturers are not an exception. Per 
Chesbrough (2012), innovation inefficiencies occur when companies operate in close 
business models lacking in exchange of technologies and intellectual property that is 
necessary to the industry and its consumers. Firms can awaken their dormant economic 
potential using outside-in perspectives and open to infusing outside ideas. By combining 
the use of internal technologies as well as a willingness to allow internal technologies to 
flow to the outside. 
Rising cost and shorter timetables in design, production, distribution, and 
technology development are costly and time- consuming factors (Chesbrough, 2012) for 
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medical device manufacturers. FDA requirements and approvals are factors affecting 
AED manufacturers. FDA approval results in an additional delay if there is a history of 
recalls. D.M. Zuckerman, Ph.D. (2011); P. Brown, BS (2011); S.E. Nissen (2011), MD, 
reviewed the FDA approval process (2011). They concluded that medical devices passed 
through the less rigorous FDA 510(k) clearance. Medical devices comprise more than 
two-thirds of the products recalls by the FDA. This process harms patients or results in 
death. When devices were intentionally exempt from any FDA review were added to the 
FDA 510(k) approved and classified devices, they comprise more than 3 out of 4 of the 
high-risk recalls during the last 5 years. Their findings reveal important shortcomings in 
the current FDA device review system and its implementation that will require either 
congressional action or major changes in regulatory policy. 
This FDA device review makes it increasingly difficult to support investments in 
innovation that result in added manufacturing pressures. These pressures include the cost 
of new product development and the expected revenue from sales to cover the cost of 
conducting business and achieving innovation. By applying an open business model, new 
brands of licensed technologies from other companies (Chesbrough, 2012) may generate 
millions of dollars in revenue and improve companies’ expenses before interest, taxes, 
and amortization (EBITA). Open business models contribute to an increase in revenue. 
These business models were a point of discussion during the interview as part of 
motivating medical device manufacturers to consider an open business model.  
Baby Boomer strong buying potential and greatest need for home AED 
solution. The baby boomer has a combined consumer buying potential of $3 trillion 
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(Parment, 2013). This constituency of consumers has the buying power and aware of 
more technical and digital devices and applications are part of the American culture 
(Behrens, Mislevy, DiCerbo, & Levy, 2010). Many retirees with financial resources are 
relocating to more remote and suburban locations. Given the trends of the aging and 
those of healthcare, the aging baby boomer may be at a higher risk than ever before. 
American Heart Association’s (2011) CPR statistics shows nearly 383,000 out-of-
hospital sudden cardiac arrests occur annually and 88% of cardiac arrests occurring at 
home. Over 932 deaths occur each day to SCA (FDA, 2013) with approximately 792 
occurring at home. If a home for the aging baby boomer is in a remote location, it implies 
a higher risk because home is where AED manufacturers have grown their customer base 
the least. There is less focus on marketing and sales strategies of AED home model, as 
well as minimal training programs by AED manufacturers to solve this issue.  
Although AED manufacturers’ marketing strategies include retail, over-the-
counter, and Internet sales by direct distributors, the marketing gap remains in both 
commercial and consumer markets. The AHA estimates more than 95% of cardiac arrest 
victims die before reaching the hospital. The lack of market penetration of these markets 
reduces accessibility to an AED and decreases a victim’s chance of survival. This 
reduction in accessibility to an AED reflects the weaknesses of previous studies and its 
outcomes. 
Growing incidences of cardiovascular diseases and disorders, combined with the 
aging of baby boomer population entering their 65th birthday since 2011, are contributing 
to the growth of the U.S. defibrillators market. Concurrently, operating expenses 
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alongside market demands are forcing hospitals to consolidate their resources and 
physical presence in metropolitan areas as opposed to remote or rural areas. The aging 
population has the tendency to relocate to more remote areas (Oswald & Rowles, 2006) 
for peace and quiet, yet medical facilities are relocating to metropolitan areas. This 
relocation factor reduces first-responder and emergency resources to the aging population 
(Shabel, 2014). This remote living is especially concerning because these individuals 
depend on ease of accessibility and quick response for urgent medical attention. Retiring 
in rural areas for the aging boomers may not be a good option if these trends continue. 
This trend is an opportunity for medical device manufacturer marketing leaders to seize 
the trend by solving the issue using mHealth devices and technologies for the rural home, 
home healthcare, and retirement home facilities. One opportunity may involve the impact 
of mobile devices and how these devices are transforming healthcare and the 
development of new medical devices (West, 2012). 
The market demands safe and easy to use features, as well as emerging 
technologies in out-of-hospital markets (Lewis & United States Food and Drug 
Administration, 2001). These features may be in concert with the boomer population 
which is more digitally centric (Oblinger, 2008). There are increasing trends toward 
installations of AEDs at workplaces by direct sales channels. No trends of AEDs home 
sales, installation, or training programs exist. This trend is a good opportunity for growth 
in the defibrillators market. With boomers, more digitally centric, coupled with no 
product recalls since 2010 (FDA, 2010), the opportunity for growth prevails. 
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Cost and risk of Healthcare in rural areas. As boomers begin to purchase 
retirement homes, the ideal landscape may include finding a rural area or small American 
town where they may find peace and serenity during their last years of life. Populations 
living in rural areas may have a risk for the aging and retiring boomers if they are not 
healthy (Shabel, 2014). Per Shabel (2014), the healthcare market demand for hospitals is 
forcing them to consolidate their presence and resources in metropolitan areas as opposed 
to remote or rural areas. This shift is especially concerning to the aging and boomer 
population because they depend on ease of accessibility and quick response as they may 
encounter cases in need of immediate medical attention. Some may advocate healthcare 
policymakers to the lobby and take action to ensure provisioning of medical resources to 
rural medical communities. This advocacy and awareness may be the opportunity for 
medical device manufacturer marketing leaders to seize the trend by solving with 
mHealth devices and technologies for the aging at home (Reeder et al., 2013). 
 Medical doctors and advocates such as Graham Nichol, Alfred P. Hallstrom, and 
Richard Kerber, have proposed defibrillation solutions in public places in which large 
numbers of older people are present (Nichol et al., 1998). Other experts in the field such 
as Myron L. Weisfeldt, M.D., Siobhan Everson-Stewart, Ph.D., Colleen Sitlani (2013) 
have concluded differently as their perspective is in medical terms. They evaluated out-
of-hospital cardiac arrests in which 2042 occurred in public and 9564 at home during the 
same period of time. Their conclusion was that regardless of whether out-of-hospital 
cardiac arrests are witnessed by EMS personnel or bystanders and whether AEDs are 
applied by bystanders, the proportion of arrests with initial ventricular fibrillation or 
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pulseless ventricular tachycardia is much greater in public settings than at home. The 
incremental value of resuscitation strategies, such as the ready availability of an AED, 
may be related to the place where the arrest occurs.  
The study underscores the number of cases at home and in need of equipment and 
bystander training, to be applied in much the same way as for the public, to prevent SCD. 
The AHA has also advocated Medical device manufacturing and distribution marketing 
leaders to assist with SCD prevention in this space. Nevertheless, manufacturers are still 
leaving their largest opportunity in the consumer market unequipped and at risk with an 
estimated 85% potential in the home and public settings (AHA, 2012). 
Starts at home: An untapped potential market. Per the AHA (2014), 70% of 
Americans may feel helpless to act during a cardiac emergency because they either do not 
know how to administer CPR or an AED. Home is where 88% of cardiac arrests occur 
(AHA, 2013) and continues to be the alarming statistic. The FDA approved 
manufacturers to market an over-the-counter AED for home use (Mayo, 2015). This 
approval contributed to the overturning of regulation, which enforced the use of 
prescriptions.  This regulation is no longer an obstacle to purchasing or using an AED at 
home.  
Automated External Defibrillators are not prevalent in homes where the initial 
intent was to protect the aging or ailing individual.  The home is where training and 
accessibility are at its minimum. Aging individuals is a potential market segment and 
issue unrecognized by medical device manufacturing and distribution marketing leaders. 
Statistics from both the AHA (2013) and FDA (2013) explicitly show more than 900 
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lives lost daily to sudden cardiac arrest. Yet initiatives to reduce SCD have not 
succeeded. Using Public Access Defibrillation (PAD) programs to assist SCA victims 
have not been an effective initiative. Focused and targeted marketing campaign by 
medical device manufacturer marketing leaders to capture the 88% of SCAs occurring at 
home, may be a more effective method. The limitations with bystander training support 
are a direct correlation to the statistics in the home and the lack of AED purchases by the 
homeowner.  
A more relevant and progressive medical device industry focus is on implantable 
cardioverter-defibrillator (ICD) technology as opposed to AEDs. This issue, coupled with 
the medical industry’s emphasis on preventive medicine, deters from AED and AED 
program advancements. By medical device manufacturer marketing, designing, and 
selling devices which provide medical assistance to patients with CVD history, the 
detraction from developments in the consumer AED space will continue. This strategy is 
reducing the potential to prevent SCD at home and provide first-responders with an AED 
solution with accessibility to the victim within 4 minutes in the critical minutes needed. 
This level of accessibility will take innovation and the ability to implement the 
technology through entrepreneurship and leadership. To summarize the opportunity, the 
combination of an open business model to seek new marketing strategies for the 
consumer goods sector may be the motivating factor. The motivating factor is for medical 
device manufacturer marketing leaders to seize the opportunity by growing their 
customer base with the baby boomer market.  
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Home AEDs. Home AED units are manual, mobile, with the ease of use built in 
averaging in price from $950 each for a low-end model to $1,200 to $2,900 for those with 
additional and automated features. Retailed by online distributors, pharmacies, and other 
medical device sales companies, their inventory includes well-known AHA endorsed 
brands.  Their value proposition features manufacturer’s warranty, turnkey solutions 
alongside the needed equipment to install AEDs at home. Training is an area which does 
not always come with the home AED solution and yet a critical part of a bystander 
assisting at home. 
According to The New England Journal of Medicine (2011) in 7,000 people who 
had a heart attack, a study showed in which one group received family training in 
cardiopulmonary resuscitation and a 911 call strategy. In the same study, a second group 
received AEDs and training to use them at home. The authors addressed the perception of 
some bystanders who involve themselves with the use of the AED and not make the 911 
call before engaging. After 3 years of follow-up, the authors concluded the researchers 
found the high-tech group had no better than the “call 911″ group because of bystanders’ 
responsive attributes.  
This study, supported by the National Heart, Lung, and Blood Institute, teaches 
doctors a few new lessons, aside from answering the primary question regarding survival 
in the two groups. The first lesson resulted in modern post-heart attack care had made 
considerable inroads in preventing late sudden cardiac death. Instead of the 4% per year 
death rate expected, the latest study documented sudden death rates closer to 1% per year. 
Only about a third of the deaths in this post-heart attack population occurred because of 
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rhythm problems treatable by the AED. Last, a third of the deaths were from non-cardiac 
causes. 
In both groups, training was an important part of taking the proper action in an 
emergency either beginning CPR while calling 911 or using an AED.  The importance of 
each situation is a trained bystander to use any of these options given the circumstances. 
If SCA was the emergency, the patient is without a pulse and an AED is the only device a 
bystander uses to bring back a victim to life (Capucci et al., 2002). By applying the AED 
within the first 4 minutes of the arrest, the survival rates for an SCA victim increase. If 
the emergency involves a victim who has stopped breathing yet has a pulse, CPR may be 
the best application.  
The home continues to be a space where most SCAs occur and yet has the lowest 
percent of AEDs and trained bystanders. Retailers and online, direct sales companies are 
not providing the necessary marketing, training solutions, and awareness to motivate 
consumers to purchase AEDs for their home. The cost associated with the purchase of a 
new AED home model deters buyers from making this decision a priority. The 
Association of American Retired Persons (AARP) does endorse the authorized 
manufacturer of home AEDs. Despite the lack of endorsement, no joint marketing 
initiatives exist informing and promoting the critical need of owning and AED most 
especially for the boomers. 
Cost-effectiveness and affordability of in-home AEDs. Direct sales channels to 
the consumer market include Internet sales, local pharmacies, and retail stores for those 
home model AEDs not needing a doctor’s prescription (AHA 2014). Home and small 
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business model AEDs made by a U.S. manufacturer are readily available for purchase 
ranging from $900 to $2,900 as well as accessories as over-the-counter products at retail 
pharmacies. As early as 2004, the FDA allowed the sale of automated external 
defibrillators (AEDs) from approved manufacturers. During the same period, an approved 
class III medical device was the only one available for purchase with a prescription. 
Over-the-counter (OTC) sale approval of AEDs belonged to one manufacturer. The FDA 
approved a second manufacturer for an equal AED class, and the list continues to grow 
(Jorgenson et al., 2013). One criterion to secure FDA approval is the safety and efficacy 
of OTC AEDs purchased for the use at home. By 2009 many of the recall and safety 
issues previously reported had been overcome by the AED manufacturers. 
Notwithstanding, the need for an AED in the home to help prevent SCD remains a 
marketing opportunity for manufacturers already approved and dominant in the 
marketplace. While the largest opportunity in the consumer market is with the aging 
population, anyone is subject to an SCA. The benefit from purchasing, training on its use, 
and possessing an AED readily available during an emergency, is prevention. 
Defibrillation is the only effective treatment for sudden cardiac arrest (Go et al., 2014), 
and yet less than 15% of homes own an AED. The evidence of lack of sales and 
proliferation of the AED is that Americans are still dying annually of sudden cardiac 
arrest. It is more evident with 88% of all SCAs in the United States occurring at home 
(AHA, 2013). The opportunity to expand the market is evident with these metrics.  
Medical device manufacturers and its distributors will need to find ways to make home 
AED units more affordable; be more engaged in their direct sales network, and build 
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partnerships with vendors which core businesses in consumer products for the aging 
population. 
AED distribution network and its products. Leading AED manufacturer use 
distributor networks as their sales footprint to capture volume of single unit sales. By 
surfing the Internet for distributors, leads to manufacturer landing pages and online stores 
selling their AED products directly. Distributors typically promote the implementation of 
the AED in dental clinics, medical facilities, schools, churches, police, and all public 
places (Palmero, Dotterweich, Lhotsky, & Walker, 2012). The marketed devices may 
include features such as the use audible speech commands and viewable signals to lead 
the rescuer through a resuscitation cycle that may include defibrillation and 
cardiopulmonary resuscitation (CPR). Certain units use rectilinear biphasic defibrillation 
waveform, and functions in either adult or pediatric modes and include both adult and 
pediatric defibrillation electrode pads.  
Manufacturer designs and marketing include devising the AED with nervous 
rescuers’ in mind because most may be experiencing it for the first time. Engaging 
bystanders willing to assist,  AED features such as soothing voice, guides the rescuer 
through the crisis with simple step-by-step instructions is a help and a good marketing 
attribute for an AED. One important feature attracting prospective clients is the AED’s 
ability to distinguish the force needed to compress the chest during CPR.  Every person 
has a different weight and physical ability. The standard measurement of chest 
compression quality is not a force but the depth of the compression.  These features 
provide ease of use and minimize error. All are good designs for ease of use and 
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expedites the process (Hallstrom & Ornato, 2004). The combination of the AED and CPR 
are the most effective in assisting a victim of SCA. 
In a real-world situation when someone has collapsed, potentially from SCA, a 
quick installation of the AED will begin to analyze whether a shock is necessary. In 50% 
of the cases to resuscitate a patient, the shock is not required. Other designs include a 
one-piece electrode to accommodate the anatomical variation. Based on extensive 
research, some AED manufacturers meet the anthropometric chest characteristics of 99% 
of the population.  
AED product attributes. During a crisis, simplified placement creates 
confidence and calmness during the critical minutes. By affixing two separate electrode 
pads to the patient’s bare chest, may be confusing to a lay rescuer. Some manufacturers 
have simplified this step by guiding the placement of red crosshairs at the center of the 
patient’s chest. Typically, the crosshairs have a hand-locator and two electrode pads 
falling naturally into an optimal position for both defibrillation and CPR. These features 
streamline the process and simplify the bystander’s actions. All AED electrodes transmit 
defibrillating electricity into the patient through metal contact patch with a salt-infused 
gel applied to the patient’s chest. Over time, the salt in the gel will corrode the metal and 
eventually compromise the electrode’s functionality. Some AED manufacturers include 
novel electrode design includes a special barrier preventing most corrosion for five years 
or more (Fries, 2012). Last, defibrillators use lithium batteries are readily available in 
most stores. They typically are good for five years and included with the unit. 
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Other features found from different AED manufacturers include a simple to 
operate turns on with easy-to-use pull handle. These become standard features, and 
design brands come as ready-to-rescue features. The AEDs installed in the carrying case, 
and battery and pads installed on the device as standard features. Some smart units 
deliver maximum shock strength using a unique combination of high current to maximize 
effectiveness and a lower energy dose to minimize side effects harmful to a fragile heart.  
AED quality control. Part of quality control, in most AED manufacturers, 
includes a 120-point test before it leaves the factory. Each AED conducts self-tests every 
single day. The AED performs over 80 different tests in all as well as the pads. The quick 
shock feature is a readiness test. This minimizes chest compression interruptions. CPR is 
more important to survival than previously realized, rapidly delivering shock after chest 
compressions are critical. This feature reduces the time between hands-off and shock 
delivery. The integrated pad test for their sensing application to the skin is their ability to 
sense from the cartridge and applied to the patient. The feature assures quality because it 
helps the first responder know what point the user is in the response process. Last, 
commonly graphics-based visual instructions with intuitive icon-driven operation and 
design must communicate instantly with minimum reading and interpretation. Users not 
familiar with the devices can follow the instructions easily. The quality control must yield 
the necessary metrics to pass manufacturer and FDA approvals (FDA, 2013). 
Medical Device Manufacturing of AEDs for the Consumer U.S. Market. 
Boomers have long been the catalyst of the aging population by living longer (AHA, 
2013), requiring quality of life and treatment option outside of the hospital, and medical 
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facilities when chronic conditions occur. Thus, home healthcare has required medical 
diagnostic and treatment devices with the capability to access remotely by sophisticated 
computer-controlled electromechanical measurement instruments. These medical devices 
located in advanced laboratories (Salditt & Bothell, 2004) are to accommodate consumer 
demand. As of 2005, medical device manufacturers have monitored the trend in medical 
devices for their design and manufacturing. Some trends include a tendency toward 
smaller, user-friendly, more portable products that require more advanced components. 
Innovation and scientific advances in manufacturing technologies and automation 
techniques add value to remain competitive.  Medical products covering the range of 
patient monitors, drug delivery systems, therapeutic devices, and life assist devices all are 
shifting from the care of in-home medical personnel to medical facilities. The use of 
devices and telecommunication remotely connected provides access to in-home patients 
to these devices.  
Aside from implantable devices such as an implantable cardioverter defibrillator 
(Bardy et al., 2010), new products are patient portable and patient wearable. 
Manufacturer designers are also responding to market demands for low-power 
components, long-life rechargeable batteries, rugged designs, simple user interfaces, and 
low cost (Salditt & Bothell, 2004). User interfaces may be an area of further research 
because many of the mobile applications and Internet connectivity is in telematics. 
Medical device manufacturers marketing leaders and distributors of AEDs have 
an unlimited opportunity in both technology and design to expand in the consumer goods 
sector of this market. Coupled with an open business model approach, marketing leaders 
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will substantially expand their customer base and remain mindful of the statistics stated 
by the American Heart Association. Statistics includes an 88% of SCAs occurring at 
home and public areas (AHA, 2013). Only 3% occur in the workplace according to the 
U.S. Department of Labor – Occupational Safety & Health Administration (USDL-
OSHA) records dating from 2003 to 2014. The remaining statistics include the 9% of 
SCAs occurring in other out-of-hospital locations. Based on the AHA (2013), the aging, 
which includes Boomers, are going into retirement requiring healthcare at home and not 
in the hospital or clinics. Because of this fact, medical device manufacturers of AED 
home units increase their total market position. 
Healthcare and Retirement Trends of Aging Boomer Population 
The aging population from the Baby Boom era is retiring. The Boomer 
Generation represents approximately 76 Million Americans born between 1946 and 1964 
(Pruchno, 2012). The first of the baby boomers reached the retirement age of 65 in 2011 
and the last group turning 50 in 2014 with women representing approximately 52% in 
both groups. Per AARP (2014), boomers will turn 65 at a rate of about 8,000 a day for 
the next 18 years. This sustained trend of a daily number of retirees will be the 
approximate number spending more time at home. Retirees may potentially be falling 
into the 88% of the SCA occurring at home with only a small amount of them equipped 
with an AED.  
Given the large volume of Americans, the Boomer Generation will influence and 
transform the institutions of aging and many others in this era (AARP, 2014). What we 
do not know is whether boomers redefine this period because of their large number, 
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buying power, or management of the boomer market as they enter their aging years. This 
unknown factor may be the redefining point in which medical device manufacturing and 
distribution marketing leaders seize the opportunity to grow their customer base by a new 
approach and strategic marketing plan. 
The growth of the aging population and SCA cases at home. Approximately 
8,000 or rather 240,000 of these baby boomers retiring per month from the current U.S. 
population of nearly 320 Million (U.S. Census, 2014). Those boomers who are 65 years 
old or more represent nearly 33% of deaths from CVD. These deaths are occurring before 
the age of 75 years, which is well before the expected average of life 77.7 years (Lloyd-
Jones et al., 2010). The 10-year window represents the boomer’s life span from the time 
they reach 65 to their expected death at 75. The window provides the largest marketing 
opportunities to this consumer by AED manufacturers to grow their customer base. The 
life span for the 76 million boomers is 28 years of sustained customer growth potential. 
The first boomers born in 1946 reached age 65 and the last born in 1964 reached their 
75th birthday. This statistic represents 28 years of profitability for any company 
marketing products and services to the Boomer Generation. 
Emerging Technologies in Medical Devices 
Medical Devices – Standardization of healthcare applications and decision 
making. In the beginning years of networking, various network protocols, 
telecommunications carriers and transport devices, computer operating systems, and data 
formatting varied. Military, private, and public networks in the world operated in their 
space. A similar case occurred with a technology platform. The principal was that by 
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agreeing on a single protocol, all connect and communicate with one another. This 
agreement was the marvel of how in 1997 Vinton G. Cerf. widely known as a father of 
the Internet and co-designer with Robert Kahn of Transfer Communications Protocol/ 
Internet Protocol (TCP/IP) and basic architecture of the Internet, orchestrated the idea. In 
much the same way, Albrecht (2012) recommended the standardization of medical 
applications. Under one platform in a domestic and international setting, all users have 
transparency of healthcare applications for trust and decision making (Rajagopal & 
Ramanan, 2011). This concept can yield many benefits to consumers and patients. 
In the future, standardization will be more prevalent because intelligent devices 
such as smartphones and tablets integrate medical applications. Enhancing medical 
applications and devices augment patient safety and information assurances, as well as 
governance, are considerations for medical device manufacturer marketing strategies. It is 
important to engage end users during the development stages of their products. 
Deploying effective and transparent communication plans which inform and support 
product specifications, applications, and safety, are additional steps medical device 
manufacturer may consider in their portfolio of marketing strategies. 
The AED and its measurement and locating limitation. Per the Food and Drug 
Administration (FDA), there are about 2.4 million AEDs installed and mounted in 
protective cases in private and public facilities across the country (FDA, 2013). The 
average AED has an expected lifespan of five to ten years. Most AEDs are not used 
within their life span. Not much wears out on these units.  Manufacturers recommend a 
monthly check for operability and updates if they have digital intelligence. The AEDs 
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have the intelligent to notify when they have failed. The intelligence is an area of 
engineering improvement and part of my patent. The United States alone is losing more 
than 900 lives each day because of sudden cardiac arrest. Finding an AED using search 
and find technology, in the community, is important in preventing SCD. Per a study 
presented at the American Heart Association’s Scientific Sessions (2015), most public 
automated external defibrillators are in buildings that are not open 24 hours a day. Thus, 
bystanders who may be near AEDs have limited access to the life-saving defibrillators in 
21 percent of out-of-hospital cardiac arrests. In this study, researchers analyzed cardiac 
arrests that occurred within approximately 300 feet of a public AED.  
Information gathered from studies conducted by the AHA (2012) requiring the 
installation of AEDs for public access defibrillator (PAD), is a driving factor preventing 
SCA fatalities to continue to grow. Legislation and advocacy are other driving factors in 
the prevention of SCA fatalities (Gilchrist et al., 2012). There is also the potential for 
closing the gap in time by using mHealth or AED technology to notify the 911 
dispatcher. The SCA victim would have a chance of survival.  Even if the technology 
existed, the average time of eight minutes for a 911 response unit to be on-site is longer 
than the life expectancy after an SCA (AMA, 2013). Last, there is also a gap in the actual 
measuring and analyzing the national coverage area and effect of bystander AED 
emergency response model. The existence of this gap makes it difficult for policymakers 
and the national healthcare community to manage. 
 AEDs and the perception of a benefit or a burden. According to the AHA’s 
chain-of-survival process (Fothergill et al., 2013), someone should immediately call 
  
46
emergency medical services, and a bystander trained in cardiopulmonary resuscitation 
(CPR) should assess the victim in need. If an individual shows no breathing and no pulse, 
the trained bystander should start chest compressions and ventilation such as CPR. The 
purpose of CPR is to deliver oxygen to the blood and to pump manually the oxygenated 
blood to the brain and other organs. CPR provides basic life support until advanced-life-
support providers take over.  If the victim is in cardiac arrest, performing CPR will not be 
enough. An AED is applied in the first four minutes of an SCA. 
Security, Safety, and Governance of AEDs for the Bystander and First-Responder 
The bystander is important to a successful AED Program. Per Go et al., (2014), 
EMS personnel treat approximately 60% of out-of-hospital cardiac arrests. These first-
responders are medical personnel certified to conduct CPR and AED application when 
necessary. Trained and equipped Emergency medical service (EMS) personnel are vital 
for these types of emergencies. Their limitation as a first-responder is their inability to 
reach SCA victims in the critical minutes after SCA occurs. Their training in security, 
safety, and governance of AEDs protects their employers and themselves from potential 
negligence under standard conditions.  Bystanders who first respond by coming to the aid 
of an SCA victim run various risks by engaging with the public. These risks are part of 
the 60% of out-of-hospital cardiac arrests. Not included in the Go (2014) study, is a 
metric recorded when delineating SCAs occurring in the public facilities from those 
occurring in other location and those with cases occurring at home. 
To solve this issue, from a total out-of-hospital perspective, the AHA (2013) 
published an advisory. The advisory recommended improving bystander CPR/AED 
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programs in communities with low bystander response performance (Bradley & Rea, 
2011). The effort was to evaluate the effect of community-based CPR training programs 
which in the United States ranged from 10%–65%. These initiatives are for the public 
and nonspecific to homes needing a very specific training and bystander CPR/AED 
program. While the intent was increasing cardiopulmonary resuscitation provision in 
communities with low bystander cardiopulmonary resuscitation rates, the program did 
not make a significant difference in the outcomes and metrics toward reducing SCD. The 
connection between out-of-hospital SCA incidents and the fact 88% of all SCAs 
occurring at home failed.  The American Heart Association focuses on healthcare 
providers, policymakers, public health departments, and community leaders (AHA, 
2013).  Yet this organization remains an important part of the bystander program and a 
resource for those of us at home. Regulatory commissions, such as the FDA, have 
established safety-surveillance strategies that rely on physicians, healthcare institutions, 
manufacturers, and patients to report medical device failures and complications through 
the Medical Device Reporting system. This reporting functions as an additional step in 
governing critical medical devices such as external and internal defibrillators (Resnic & 
Normand, 2012). 
Many traditional AED/CPR courses are provided by the Red Cross, the American 
Heart Association, private companies, as well as online courses on the Internet. These 
AED/CPR courses are for community and workplace participants like teachers, coaches, 
camp counselor, school bus drivers, personal trainers, daycare workers, babysitters, as 
well as construction workers and others. The courses vary in time to complete, although 
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most courses are approximately 45-60 minutes. The assumption that students trained 
under this AED/CPR course content are professionals would not be accurate. The 
assumption that a quick refresher AED/CPR course will provide expertise would also not 
be accurate. The assumed correlation between heart attacks and cardiac arrest with aging 
adults, or those with known heart issues, may be misleading. Unfortunately, anyone can 
go into cardiac arrest without warning. Another characteristic is not tailoring these 
training programs specifically to families with knowledge of how to be an effective 
bystander. The truth is that litigation is always a potential issue despite the protection of 
the Good Samaritan clause. Skilled personnel acting as bystanders, in best-performing 
nursing homes settings, are also sued. The hope is to subvert someday the capacity of 
litigation to provide incentives to deliver safer care (Studdert, Spittal, Mello, O’Malley, 
& Stevenson, 2013). 
Saving a life is as easy as opening an automated external defibrillator (AED) 
located in almost every public building and workspace. The AED and a bystander are the 
only medical solutions known to resuscitate a victim during SCA (Go et al., 2014). As 
previously mentioned, 88% of all out-of-hospital SCAs occur at home (Go et al., 2014). 
Yet less than 15% of homes have an AED (Go et al., 2014). Current research indicates 
the chance of surviving SCA improves by 70% by applying an AED within the first 3 to 
5 minutes (Go et al., 2014). In these few minutes, the best resources and trained first-
responders do not make it in time.  
In the athletics arena and school campus settings, it is recommended by the 
American Heart Association (AHA, 2013) that AEDs be part of an Athletic Trainer’s 
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emergency action plan. Action plans as these alongside classroom-tested kit empowers 
educators to teach CPR to hundreds of students. In most university campuses, the athletic 
trainer has an AED accompany them with additional units accessible on campus. 
According to the American Heart Association, more than 250,000 people die every year 
from sudden cardiac arrest. Up to one in every five of those deaths is preventable with a 
defibrillator. Campus personnel and athletic department trainers effectively apply AED 
and CPR within 3 to 5 minutes if they are the first person on the scene. In the same way, 
a home AED must include an AED program with the AED unit. Automated external 
defibrillator manufacturers have the option of initiating solutions. The chain-of-survival 
community is one option which provides resources and entities such as the Red Cross, 
and the AHA.   
Transition and Summary 
In Section 1 of this study, I covered the fundamental issues surrounding the 
limitations of current marketing strategies by medical device manufacturing company 
leaders to expand their U.S. AED customer base. I also discussed its relationship to the 
market potential and several U.S. homes without (Frost & Sullivan, 2012) AED 
programs. The research study statement underscores the general business problem with 
medical device manufacturing and distribution marketing leaders not maximizing a 
potential in the U.S. consumer AED markets.  
The specific business problem describes a shortcoming by the medical device 
manufacturing company leaders possessing limited marketing strategies to expanding 
their AED consumer base. An overview of the issue described in this study includes 
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potential reasons and repercussions. The overview includes deprivation of just-in-time 
defibrillation to SCA victims. Various literature review and data uncovered several 
research options. One option is the qualitative approach to capturing in a multicase study 
manufacturer marketing leaders’ business model, behaviors, and marketing strategies. 
This approach infuses and influences an open business model and focus on the home 
AED as a target market. In Section 1, I also covered relevant past and current studies 
surrounding the concept AED programs, regulatory issues, and its relationship financial 
performance of AED manufacturers and healthcare cost savings. Section 2 includes the 
purpose statement, role of the researcher, participants, as well as the research method and 
design. Section 3 includes the analysis, discussion of results, as well as potential 
implications for business practice and social change. 
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Section 2: The Project 
Since 2010, medical device manufacturing and distribution marketing leaders 
have experienced a substantial increase of AED sales in the U.S. market (Frost & 
Sullivan, 2012). This experience has predominantly been from an increased public 
awareness of SCA, defibrillation, and a ubiquitous need across community landscapes for 
accessibility to AEDs and its training programs (AHA, 2014). Interest by various 
stakeholder groups regarding preventive health against CVD and CHD have all 
contributed to the increase in sales by pursuing their respective needs and initiatives. 
Stakeholders include companies seeking their interest in safeguarding their employees; 
U.S. government’s initiatives of AED placement in public facilities; and the public with 
community-based PAD programs.  
Despite public awareness and programs throughout the medical community and 
public sector, some medical device manufacturing and distribution marketing leaders are 
not yet maximizing their sales potential in the U.S. consumer AED markets where most 
SCAs occur. The lack of maximizing their sales potential is creating an abundant 
opportunity for a nonservice customer base growth. It appears that medical device 
manufacturing company leaders may have limited marketing strategies to supply the 
expansion of the AED customer base.  
Through this multicase study, I explored marketing strategies and business 
models in an effort to uncover medical device manufacturing company leaders 
perspectives on these concepts and approach to expanding their U.S. AED customer base. 
I also explored the market potential of U.S. unequipped homes public settings (Frost & 
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Sullivan, 2012) with AED programs. Outcomes from this research may include the 
uncovering of new marketing strategies and business model opportunities for AED 
manufacturers. Other outcomes may include identifying emerging AED markets, 
improving survival rates, and improving the quality of life for SCA victims. Other areas 
explored include emerging technologies and contributing towards reducing healthcare 
costs.  
Purpose Statement 
The purpose of this multicase study was to explore the marketing strategies 
medical device manufacturing company leaders use to expand their consumer customer 
base. The research method is qualitative with a multicase study as the research design. 
The population included medical device manufacturing marketing professionals from the 
top 3 U.S. companies, its distributors, and healthcare professionals. During the research 
and interviews, it was determined that while they were aware that the consumer base was 
expanding, their marketing strategies were not focused on this space.  
A qualitative multicase study is a valuable method for research to develop theory, 
evaluate programs, and develop interventions (Baxter & Jack, 2008). The subset of the 
sample was the company’s consumer goods division responsible for the U.S. market. 
Expected outcomes of the research include convincing corporate leaders of their potential 
and financial gain. The sample may also contribute to business growth in the medical 
device industry and assist in reducing the $100 billion in annual expense for U.S. 
consumers (Heidenreich et al., 2011). As part of social change, the use of AEDs may 
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prevent the loss of the lives of more than 350,000 SCA victims dying annually of which 
88% are occurring at home and within public settings (AHA, 2013).  
Role of the Researcher 
The data collection process for this qualitative study includes interviews with 
AED manufacturing marketing, distribution leaders, and healthcare professionals, as well 
as reviews of companies’ website material, analyzed data, and the findings. The purpose 
of the interviews was to gather objectively relative information and have firsthand 
knowledge from the interviewee regarding the case study (Lawrence & Tar, 2013). My 
role included developing and planning the interview from interfacing with manufacturer 
leadership and understanding their operations model. Their PLC and business model was 
also included in my interviews. During the interviews, I ensured correct scheduling as 
well as playing the role of interviewer by contacting their respective public information 
officer (PIO) or administrative assistant in advance and providing pertinent information. 
Throughout the data collection process, I focused on the fundamentals of the 
research in uncovering answers to questions and collecting the evidence while producing 
new findings not determined in past studies. I also considered marketing applications 
after this study. The qualitative research was effective in ascertaining company’s core 
values,  business acumen, and awareness of market opportunities. However perspectives 
on infusing an open business model in the organization were not received well by the 
manufacturer, yet effective with the distributor network leaders and healthcare 
professionals.  
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As the researcher, I followed ethical procedures and protocol congruent with 
Belmont’s Report. The Belmont Report published July 12, 1974, and based on the 
National Research Act (Pub. L. 93-348), signed into law and creating the National 
Commission for the Protection of Human Subjects of Biomedical and Behavioral 
Research. The report drove changes to the Commission by identifying the basic ethical 
principles and emphasizing their importance of conduct by biomedical and behavioral 
research (Faden et al., 2013). The specified conduct and behavior was regarding human 
subjects, and it included guidelines to assure research by these principles. Important and 
prevalent situations include medical, nursing and caregiving settings (Sims, 2010) where 
ethics in healthcare are especially necessary. 
I remained objective during this research to ensure a scholarly approach to the 
study of authentic interest, motivation, inquisitiveness, and commitment to uncovering 
the data objectively. I secured objectivity by focusing on the business problem, adhering 
to the research process, and retaining an outside-in perspective during interviews with 
participants. The researcher has an integral role in the process and is the main instrument 
of data collection (Bansal & Corley, 2011). The data collected from the research was 
analyzed and compiled for independent interpretation. By following this plan, I ensure 
the quality of research was conducted and free of bias and personal views.  
The interview protocol is an important tool for mitigating bias and viewing data 
without a personal influence. The interview protocol helps one retain an outside-in 
perspective during interviews. I utilized an interview protocol as a tool to assist in 
reducing biases. An interview protocol is a comprehensive instrument that researchers 
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use to assist with data collection (Jacob & Furgerson, 2012). The protocol included 
interview questions with procedural guidelines to assist participants in conducting the 
interview from beginning to end. By following the interview protocol, I achieve 
consistency across all interviews.  
As the researcher, I focused on becoming knowledgeable of the facts during the 
study. I remained cognizant of the importance and potential of infusing of new marketing 
strategies and open business models for AED manufacturers and their distributors to 
expand their customer base. As a part of the study, I plan to acknowledge potential 
implications for positive social change. The implications include the potential to save the 
lives and quality of life for over 350,000 SCA victims dying annually (AHA, 2013). 
Other implications include reducing annual expense for U.S. consumers (Heidenreich et 
al., 2011). 
Participants 
In this qualitative study, I chose a multicase study of the dominant leaders of 
medical device manufacturers and have selected three PseudoAED, U.S., AED 
distributors, and healthcare professional companies. I included six participants from the 
manufacturers, distributors, and healthcare professionals. The participants represented 
three important areas, which include marketing, sales, and product development from 
their respective consumer goods division. The participants chosen were the most eligible 
to discuss the infusion of new business models. As marketing professionals, they 
influence any change in marketing strategies. By following the respondent selection 
process, it assisted me in achieving triangulation by interviewing, assessing collected 
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data, and exploring company’s website from multiple corporations and their perspectives 
on the general and specific problem stated in this study.  
Study participants, with the unique and specific ability to provide relative and 
quality data, contributed answers to research questions during data collection (O’Reilly & 
Parker, 2012). Their contribution assisted in reaching the point of data saturation 
(Marshall, Cardon, Poddar, & Fontenot, 2013). Achieving saturation included data 
review and new relevant information, perspectives, and experiences no longer appearing 
from additional interviews (O’Reilly & Parker, 2012). Gaining access to these marketing 
leaders was very difficult in part because some were still undergoing their PMAs while 
others very leery of releasing sensitive marketing information that would end up with 
their competitors. My initial approach was to use traditional and professional forms of 
communication.  
Other strategies included social media connections and professional organization 
networking. However, they were not very effective. A last and final attempt was 
leveraging their social responsibility for companies of this size as part of their operating 
business and community outreach model. By identifying their community initiatives, it 
reminded them of their company’s mission statement and thus helped me to connect and 
began collaborating with senior leaders and other company employees. In contrast, 
leaders from the distribution channels and healthcare professionals were very open and 
receptive. 
The initial interface established contact with potential participants and company 
employees. After establishing contact, I remained mindful that they are employees of 
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high responsibility and are decision makers in their respective companies. The selection 
of these participants was an important and an integral component of the research process, 
as well as remaining objective in their selection and maintained a perspective in 
mitigating personal bias. In forming conclusions from the data collected from these 
participants, there were no limitations in participant selection or influence to the quality 
and outcome of the study (Reybold, Lammert, & Stribling, 2012). 
The choice of the participants from multiple medical device manufacturers, 
distributors, and healthcare corporations created a unique representation of senior-level 
marketing, sales, and product development leaders responsible in some capacity for the 
U.S. AED consumer market. The research questions previously prepared for the 
interview were consistent with the protocol. The study included researching participants’ 
current and potential strategies for emerging markets. The purpose was to explore their 
ability to contribute to the development of a new customer base in the AED marketplace. 
By exploring their plans for expanding public, consumer, and private accessibility, there 
is a likelihood a contribution to positive social change will arise. Most of the previous 
studies, in this space of study, have not included the aging population entering retirement 
as an emerging market or specific focus on in-home AEDs as a gap in market need or 
demand.  
The qualitative approach yields the criteria of objectives and personal 
interactions, which were needed during information and data collection. The qualitative 
information will consist of personal interviews, assessment of collected data, and 
documents review to address the specific business problem. By probing and exploring the 
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company’s perspective on open business models, it yields the necessary data for this 
study. Exploring the company’s existing marketing strategies and plans with a medical 
device manufacturing company and distributors’ leaders to expand their customer base 
was an important objective.  
Research Method and Design 
An exploratory, multicase study design with the qualitative approach was the 
most appropriate design for this study. I chose the qualitative method over quantitative 
and mixed methods because of the personal nature of this approach (Ritchie, Lewis, 
Nicholls, & Ormston, 2013). The qualitative research method was appropriate for this 
study.  The research method determined the planning and strategy point at which medical 
manufacturing and distribution marketing leaders decide, or not, on AED products and 
marketing strategies of their AED home units. The further determination to address 
customer base expansion, based on current and emerging markets, was one of the results. 
A case study was more appropriate for this research than phenomenology, narrative, 
grounded theory, or ethnographic design. In-depth interviews were the most appropriate 
for collecting data on naturally occurring behaviors in their usual contexts. In-depth 
interviews were one method of data collection used in this study (Muskat, Blackman, & 
Muskat, 2012).   
My research approach involved exploring this case using more flexible and 
interactive style of elicits questions categorized with each response for analysis. The 
analytical objectives included their description and explanation of their relationship to 
each interviewee and group norms where applicable. The study design was applied to the 
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order of questions as well as additions, exclusions, or choice of particular questions 
derived from my interviews, data collected, and company websites reviewed (Muskat et 
al., 2012).  In contrast, the selection of study design includes consistency in the approach 
when developing interview questions, data collection, and analysis with the approach 
taken (Lewis, 2015). Likewise, the consideration for a single-case versus a multicase 
study was part of the planning as well as its design congruence (Barlow, Hersen, Barlow, 
Nock, & Hersen, 2009). The information was then incorporated into the analysis and the 
reflection phase of this study. 
Method 
Qualitative approaches to information gathering involve direct interaction with 
individuals in a one-on-one or group setting. The purpose of the research was to find the 
answers to important questions (Marshall, 2010). By researching, it provided me the 
opportunity to understand experts’ perspectives of the AED U.S. market, target markets, 
and awareness of emerging markets and product technologies. These qualitative data, 
gathered through the interviews, help me to address the specific business problem 
through a case study of multiple medical device manufacturers. The interviews included 
open-ended questions aimed at uncovering what strategies and potential strategies 
medical device manufacturing company marketing leaders, AED distribution channel 
leaders, and healthcare professionals using to expand their AED customer base in the 
consumer space. Interviews helped me to gather data to understand what strategies these 
leaders are using and what potential strategies may develop. 
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Research Design 
The research design of this study was a case study. The case study was the most 
appropriate for this study allowing for detailed exploration of more current information 
within relevant subject matters while using multiple data collection and analysis 
processes (Yin, 2013). Yin (2013) underscored the choice of selecting a multiple or a 
multicase study for exploration as a choice for the researcher. I explored the strategies 
marketing leaders from a medical device manufacturer are using to develop their 
customer base, or not using, and emerging technologies in the AED consumer goods 
market.  
I used multiple sources of data collection such as semi-structured interview 
questions and documentation thereby making the case study most suited for this research. 
Both the qualitative study and its design method contributed to the resolution of the 
business problem. Each question provided opportunities to describe the experiences and 
perceptions of the medical device manufacturer marketing leaders, distributors, and 
healthcare professionals on the topic of open business models (Chesbrough, 2012). 
Reaching data saturation occurred after having leveraged the three types of data 
collection to the point at which there was a diminishing return in collecting more data 
(Marshall et al., 2013). These types include interviewing, assessing collected data, and 
reviewing the companies’ website material. While collecting the data, I ensured there 
were the necessary quantity and quality as part of reaching saturation. 
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Population and Sampling 
Population and Sampling 
In choosing participants, I used a purposeful sampling approach. Participants of 
choice were from marketing management as well as change agents with decision-making 
responsibility and influence in their respective company. Participants of choice have 
influence with company steering committees and vision-sharing in strategic direction. 
This choice of sampling was in accord with Reybold et al. These authors depicted 
purposive sampling as the strategy of achieving the best fit data to answer the research 
question, making the best use of resources, and completing the study with resources 
available (Reybold et al., 2012). In purposive sampling, the participants selected had 
information that was relevant to the study (Petty, Thomson, & Stew, 2012).  
A critical fundamental of creating credible research was obtaining an adequate 
sample (Marshall et al., 2013). To reach data saturation with a minimum of six 
participants by performing interviews with the respective participants, selecting a sample 
size was contingent on the need to reach data saturation. Saturation is the point at which 
diminishing returns in collecting more data exists (Marshall et al., 2013). Because the 
number of participants in this study was sufficient, reaching saturation was foreseeable. 
Their intellectual knowledge, decision-making responsibility, and access to resources 
allocation included important information which added value to this study.  
I conducted the interviews by telephone with the option of audio recording when 
permissible. In the interview process, I targeted marketing leaders who were responsible 
for the U.S. market in the consumer and distribution groups. These marketing leaders 
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were from senior management ranks as well as change agents with decision-making 
responsibility and influence in their respective company. The preferences in participants 
were those who are responsible for strategic planning and marketing of the AED 
consumer goods product line.  
The participants interviewed were the most eligible interview candidates to 
engage in my study and had the decision-making authority in infusing a new business 
model and influence change in marketing strategies. In the regards to the medical device 
and AED manufacturers operating in the United States, I formally approached (see 
Appendix A as sample letter of cooperation) all three which included Pseudo AED U.S, 
Pseudo2 AED U.S., and Pseudo3 AED U.S. I also approached Pseudo AED Distributor 
U.S and Pseudo AED Distributor2 U.S because of their unique distribution models. 
Because of their market presence and focus on health consumer products, the inclination 
was towards Pseudo AED U.S. (Noel & Van Groningen, 2014). These manufacturers 
engage in healthcare products and medical device manufacturing, specific to AEDs with 
proprietary business models and research and development (R&D) groups. I found more 
success with AED manufacturers distributors willing to share detailed information, to 
some degree, than from medical device manufacturers. In contrast, both medical device 
and AED manufacturers would not relate emerging market information in the consumer 
space, nor were there any contingencies on the willingness of participants to share it. To 
ensure all participants provide available data, I chose companies with public information 
available.  
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A point of saturation was achieved by performing interviews with a minimum of 
six participants from their respective companies and area of responsibility, coupled with 
sources of data from the company website and interviews. The point of achievement was 
reached whereby there were no new information or topics, contributing to reaching a 
point of saturation (Marshall et al., 2013). I conducted the interviews by way of 
conference calls to ensure depth of research by checking in with all participants to 
validate their responses.  
Respecting participants’ time, I conducted telephone interviews with brevity and 
efficiency, anticipating no longer than an hour in uninterrupted chambers. These 
accommodations are important as they are leaders and an important stakeholder in the 
company (Harvey, 2011). Jacob and Furgerson (2012) recommended that participants 
conduct interviews in a quiet and private location. The purpose was to minimize 
distractions, allowing for clear and audible communication, and to ensure data 
confidentiality during data collection. I reviewed the protocol and consent form process 
with participants to ensure compliance and sustainability throughout the fact-finding 
process. 
Ethical Research 
Research ethics is the interaction between researchers and the participants they 
study. The professional aspect of research ethics involves the issues of researchers’ 
interactions with participants. Research ethics includes intellectual property, mentoring 
relationships, any potential fabrication of data, as well as plagiarism. As a researcher, I 
was under the obligation to demonstrate trustworthiness and credibility as I execute the 
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methodologies used in this research. This demonstration provided an ideal opportunity to 
employ ethical literacy as I engaged in these contemporary methods (Jackson, 2013). 
Because this study specifically involves human participants, I made certain to 
include participants’ protection documents, consent forms, and a letter of cooperation. 
Participants’ names and contact information are not recorded in the research records. 
Participants’ names and information gathered from the interviews remain confidential. 
Maintaining ethical conduct was imperative, especially while conducting research to 
protect the rights of human participants. Once in receipt of approval from the 
manufacturer, distributor, and healthcare professionals, I proceeded with the interviews 
because I expected to eliminate any foreseeable conflict of interest. The research 
procedures did not reveal criminal activity or child/elder abuse that necessitates reporting. 
The research procedures did not reveal or create an acute psychological state that 
necessitates referral. 
Participants signed a consent form before the interview. I obtained Walden 
University Institutional Review Board (IRB) approval for this study. The IRB approval 
ensured the ethical protection of human subjects (see Appendix B). The words within the 
consent form adhere to the U.S. Food and Drug Administration, Department of Human 
Services and Walden University standards. At the time, I performed these interviews, I 
followed the interview protocol (see Appendix C). I completed the National Institute of 
Health Human Research Protection training (see Appendix D). As part of the protocol, I 
provided each participant with a copy of the inform consent document. Securing 
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signatures and scheduling a discussion with each participant was part of the interview 
protocol.  
I ensured there was ample time to answer any questions they had and explained 
the purpose and reason for the study as well as their rights to withdraw. The importance 
of reviewing procedure and protocol is to affirm and underscore the confidentiality and 
voluntary process. The role of the IRB is to ensure research proposals are meeting the 
criteria of applicable law for acceptability, institutional regulations, and professional 
conducts and practices standards (Jackson, 2013). I actively anticipated and addressed 
each ethical dilemma occurring at every phase of the research. I also respected vulnerable 
populations and avoid putting participants at risk (DuBois et al., 2012). I did not 
interview participants who may have been members of a vulnerable population. I 
supported every decision with a scholarly peer-reviewed or a seminal source. 
Last, I am maintaining the data in a safe place for 5 years after the date of the 
published date to protect the confidentiality of participants. As part of compliance and 
incentives, I will provide the senior management and participants a final copy of my 
findings. I am protecting the names of individuals and organizations by pseudonyms, to 
keep the participants and organizations confidential. This information is part of the 
consent statement and nondisclosure agreement. 
Data Collection 
Instruments 
In the data collection process, I ensured the study sustained a qualitative 
interpretive research and the basic framework in collecting data and analyzed. The prior 
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research did not provide a framework for this study because it is in the public and 
business sector and not in the consumer space. The lack of a framework created a need to 
add to the research, seek new data, and instruments. The researcher is the main 
instrument of data collection in qualitative research (Bansal & Corley, 2011) contributing 
valuable information used for validation and proof.  
I used open-ended questions to allow the participant to expand or emerge on the 
subject matter or phenomenon in question. I used semistructured interviews with leaders 
of the medical device manufacturer with questions regarding their marketing strategies 
and emerging technologies to expand their consumer goods customer base. Congruent 
with this approach, I sustained my role as the researcher by effectively interviewing each 
participant gaining clarity and consistency with each question; assessing collected 
organized and coded data, and reviewing the manufacturer’s web material for any 
variance between data collected and data published. During the data collection process, I 
validated the necessary quantity and quality in each area of research as part of reaching 
saturation.  
To gain profound experiences or views on a subject matter in this qualitative 
study, I followed Silverman (2013), and relied on interviews to gain as much detail as 
possible. In the initial permission letter to the medical device manufacturer, distributors, 
and healthcare professionals, I requested permission to initiate contact to introduce 
myself as the researcher and establish the premise of my study. Once the institutional 
review board (IRB) approved my proposal, a letter of cooperation to the participating 
companies followed, requesting permission to begin the interview process. The 
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information about the instrument that I planned to use was conveyed, pertaining to 
demographics and how it would remain congruent with other instruments used in 
previous studies. I overcame the disadvantage of being on the participants’ premise face-
to-face by utilizing telephone calls and audio recording capabilities when allowed 
(Pickard, 2012). 
As the researcher, I continuously uncovered any relevancy between the analysis 
and data collection and data analysis guides in data collection (Buckle, Dwyer, & 
Jackson, 2010). The three levels of analysis included the presentation of the data without 
interpretation and abstraction. The second inclusion was a descriptive narrative using 
field notes, interview transcripts, and researcher interpretations. The third inclusion was 
building a theory based on interpretations and abstractions. Coding was a part of the data 
collection process for data taken from field notes and interview transcripts. By coding the 
data, I fractured the data and grouped it into codes for categorizing confluent events, 
statements, and identifying the data (Holton, 2013). The research procedures and the 
analysis/write-up plans were performed based on the data coding and not on the raw data 
containing any participants’ identity. I develop a theory to explain what will happen to 
the data. To determine what will happen to the data, a series of questions were used to 
form the theory.  They will be:  
1. What phenomena do these data represent? 
2. What category does a given incident indicate? 
3. What is happening in the data, beyond the surface-level explanation? 
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I, as the researcher, used open coding to determine the theoretical sensitivity, transcend 
descriptive details, and encouraged a focus on patterns among incidents yielding codes. 
I took several steps to ensure reliability and validity of data collected from the 
interview process by quickly transcribing the interview recordings and ensured accurate 
interpretation of the responses from participants (Yu, 2012). Upon completion of the 
interview and the interpretation of their response, I allowed the participants to verify the 
accuracy of the transcript through both telephone conversation and email allowing up to 
10 days to review and return, as described in Seidman (2012). Participants reviewed their 
respective transcripts and verified that the transcriptions were correct. There were no 
discrepancies noted and secured an agreement with all participants ensuring that the 
research accurately interpreted his/her intended response for each question. 
Documentation was an important source of case study evidence from this research. I 
conducted a review of any documents on the study topic such as reports or studies. I 
retrieved information from the company’s website regarding AED products, services, 
education & resources, specialties, marketing initiatives, financial posture, and 
innovation paradigms. I also retrieved information from FDA websites related to 
compliance and regulatory policies of AEDs, as well from a medical journal, and medical 
organizations and other governmental websites to reach triangulation. The responses 
across participants and corroborated data from the document review process were part of 
facilitating the convergence of data (Yin, 2014). 
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Data Collection Technique 
The interview protocol included information, guidelines, and prompts to assist 
with executing the interview from start to completion and to assist with maintaining 
consistency across interviews (Jacob & Furgerson, 2012). I followed the procedures 
outlined in the interview protocol to conduct the interviews. The interview script had an 
introductory script. The script included the consent process which allows participants to 
ask questions. Because I was aware of the AED manufacturers’ involvement of their 
requirement to respond to the FDA’s PMA enforcement, there was an inclination with 
these companies to conduct all interviews by telephone only. The purpose of the 
interviews was to ensure accuracy and quality of each response to the research questions. 
As the researcher, I made it my responsibility to secure and document the answers to the 
questions and verbal responses. I used the following interview techniques to ensure the 
interview process is effective in fully engaging participants. Jacob and Furgerson (2012) 
recommended that researchers limit note taking during interviews so as not to distract 
from maintaining eye contact with the participant. I requested permission to record 
interviews to minimize the need to take notes.  
Regarding the interviews, I requested from all participants to conduct the 
interviews in a quiet location (Jacob & Furgerson, 2012) and thus, all resulted at their 
business office. In making this request, it helped to eliminate distractions while ensuring 
privacy and confidentiality of the data collected. Documented interviews and meetings 
related to the topic provided an additional opportunity. 
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Advantages associated with using interviews recordings, as a source of data 
collection, was included as an option to participants when permissible by management 
and participant. This option allows researchers to capture data not previously recorded 
(Yin, 2014). The advantages also provided me an opportunity to listen to participants (see 
Doody & Noona, 2013). Audio recordings allow the researcher to replay the interview to 
capture details (Yin, 2014). Telephone interviews eliminated traveling and demands for 
more time to reach participants as well as adding travel expenses. Six telephone 
interviews were conducted each by telephone with no on-location interviews 
In these remote access interviews by a telephone call, I secured prior approval 
from participants to record the interviews as indicated in the consent form. Each 
participant provided a signed consent form before his or her interview by email (see 
Doody & Noona, 2013). If the participant did not provide approval to having the 
interview recorded, I did not use audio recorders and only took notes.  
Skype works over the Internet. My safety net for a possible weak connection was 
to use other devices and telecommunication transports. This alternative was a good 
prevention plan in avoiding disruptions to the interview process (see Hanna, 2012).  
A poor interview was experienced with one of the AED distributors, however, it 
was mostly due to an overcommitment of time by the marketing leader. Although 
agreeing to participate in the interview, the focus was more on the existing PMA 
response to the FDA at the headquarters, than on the interview. I concluded the interview 
and both agreed on reconvening later. This resulted in a portrayal of mutual respect for 
critical tasks and professionalism.  
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Internet connectivity may vary depending on various components and services 
because of telecommunications providers and equipment. Although Internet or 
telecommunications connectivity never failed during the interviews, rescheduling was 
always an option. Reviewing the manufacturer’s website material was part of the research 
and assurance of the collection quantity and quality needed utilizing editing tools, notes, 
written questionnaires, and saturation.  
Data Organization Techniques  
During my research, I requested permission from the participating companies to 
record all conversations during the interviews using a digital voice recorder device. 
However, because of their concern for security, in most cases, I was not permitted. My 
plan, after each interview, was to have the recordings from my iPhone uploaded using 
iCloud technology to download on my computer system in a password-protected 
database. Additional steps of precaution included backup to the cloud provider for safe 
keeping and identifying the recordings using labels to protect the identities of participants 
(Fernando, Loke, & Rahayu, 2013). The systems used for keeping track of data included 
a recording of teleconferencing; digital and hard copy transcribed notes; and answers to 
the structured questions, as well as information from manufacturer’s website.  
Regarding maintaining records and chronology, all documents such as schedules, 
logs, journals, and labeling systems are being kept within the database. I secured all 
consent forms containing participants’ interviews and any other research material in the 
protection of any privacy risks. Maintaining data in a bank lockbox for a minimum of 
five years after the date of the published date will be my protocol to ensure compliance 
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and safekeeping for this study. After 5 years, the data will be destroyed by contracting a 
security company to protect the privacy of consumer information and reduce the risk of 
fraud and identity theft.  I have taken appropriate measures to dispose of sensitive 
information derived from participant interviews and any other information, through such 
a company. 
Data Analysis Technique 
The data analysis technique included the review of the data without interpretation 
and abstraction. A descriptive narrative using field notes, interview, transcripts, and 
researcher interpretations was part of conducting an analysis of these interpretations and 
abstractions. To analyze these data gathered for analysis from these in-depth interviews, 
assessment of data collected, and company website, I used the modified van Kaam 
method (Van Kaam, 1959). My objective was to identify the themes from a purposive 
sample of a leading medical device manufacturer with approved consumer type AEDs by 
the Federal and Drug Administration (FDA). I used various applications, such as MS 
Word and Excel from the Microsoft Professional Suite software, to store the data 
collected in this study. I chose this application compared to NVivo and Atlas.ti software 
because of my familiarity with the use of the Microsoft Professional Suite and analytical 
attributes. Each decision supported with scholarly peer review references.  
Yin’s (2014) recommendation depicted the creation of a case study database in 
data collection as one to store the information collected. I stored all field notes, data 
collected from interviews, transcripts, and information from company official websites on 
a password-protected database on my computer in which I have sole access. I maintained 
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reliability and validity of the study (Yin, 2014) by rigorously following the protocol and 
process set forth by this study. Using a tree format of folders, I organized each by the 
participant with subfolders as supporting document to each interview as follows:  
Folders 
S 1-10 
Sub-Folder 
Inter1-6 
Coding 
X or O 
Coding Levels  
1-10 Positive or 0-(10) Negative 
The database had a password protection feature and stored on the computer for 5 
years. After 5 years, I will delete all raw data stored and collected from each of the files 
with the case study database. I will destroy all printed documents in the bank lockbox by 
shredding and discarding all documents using contracting a security company. As 
stakeholders of the company, participants are eligible to receive written results of the 
study. This is part of data organization and analysis protocol. 
Confirmability and Replicability 
Confirmability 
In the quest to bring a unique perspective to this study, I confirmed and 
corroborate with other subject matter experts in the field. I accurately measured a 
qualitative study as past authors have enriched us with various potential concepts. I 
  
74
documented the procedures for detailed inspection and checking of the data throughout 
the study. One method is confirmability defined by Petty, Thomson, and Stew (2012) as a 
paradigm shift from such methods of measures as reliability. Reliability defined by 
authors as Krefting (1991), focusing on the assessment of trustworthiness, confirmability 
validates the assessment and the findings reflect the focus of the inquiry. Venkatesh, 
Brown, and Bala, (2013) recommended the use of multiple sources to ensure reliability 
when conducting qualitative studies as well as one mixing qualitative with quantitative 
when considering participants and interview questions. Yin (2014) is consistent with 
Venkatesh, Brown, and Bala, (2013) because using multiple sources of data such as 
semistructured interviews and document reviewing also improves the reliability of a case 
study. Poortman and Schildkamp (2012) expand on the use of a tool to document 
systematic steps and procedures for data collection allowing consistency across 
interviews thus making the research reliable. Poortman and Schildkamp defined 
reliability as the measure of how replicable the research findings are independent of the 
researcher and instrument.  
By implementing recommendations from previous authors to achieve reliability, 
various measures throughout the research process for this study and data collection did 
take place. By allowing participants to review the analysis summary of the study results 
based on my interpretation of the interview data (Yin, 2014) is further evidence of 
achieving reliability. Yin suggested using multiple sources of data such as semistructured 
interviews and document also reviewing improves the reliability of a case study. After 
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completing the study, I conducted a data audit to examine my data collection and analysis 
procedures and did not uncover any potential bias or distortion.  
Replicability 
Replicability, validity, and triangulation, per Golafshani (2003) as relevant 
research concepts, must be redefined to reflect the multiple ways of establishing the truth. 
Validity in research was this researcher’s goal to ensure it was, in fact, the conclusion or 
derivative of the research reaching to the truth (Denzin & Giardina, 2012). Per Denzin 
and Giardina, subdividing validity into four types addresses a specific methodological 
question. I explored the methods and approach on how to investigate a research question 
while seeking validity. I researched for data triangulation and secured it, which is a 
technique that facilitates validation of data through cross verification from two or more 
sources (Myers, 2013). The purpose for using triangulation was for additional means to 
improve the credibility of the research findings. I achieved triangulation by interviewing, 
assessing collected data, and exploring company’s website from the same corporation 
regarding the general and specific problem stated in this study. As part of the qualitative 
research for credibility, I described the participants’ understanding of the subject matter 
to best describe it from their perspective. As in the interviews, I took the same approach 
while extracting information from PseudoAED U.S. manufacturers’ websites, checking 
each response, and the transcript review to validate and triangulate the data. 
Transition and Summary 
In Section 2, I described the methodologies and strategies that I used to approach 
this study. The qualitative method of research, specifically a case design, has 
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demonstrated to be the best method to approaching this study. I described how 
conducting a qualitative research would yield the criteria of objectives and personal 
interaction needed to information and data collection. This qualitative information, 
through a multicase study with personal interviews, helped me to explore marketing 
strategies and business models related to consumer AED market in the United States. By 
exploring leaders perspectives in a leading medical device manufacturer, I uncovered 
their motivation, or the lack thereof, toward an open business model to grow their 
customer base.  
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Section 3: Application to Professional Practice and Implications for Change 
In Section 3, I present my findings alongside implications for professional 
practice and social change. Section 3 includes my recommendation for reflections of all 
phases of the study and further study. The qualitative method, specifically a case design, 
was the method of approaching this study (Corbin & Strauss, 2014). Conducting 
qualitative research provided an opportunity for personal interaction needed during 
information and data collection. This qualitative information, through a multicase study 
with personal interviews, helped me to explore marketing strategies. These strategies 
included the relationship related to the consumer AED market in the United States. By 
interviewing psuedoAED leaders of the consumer goods division, AED distribution 
leaders, and healthcare professionals with the potential of motivating them toward an 
open business model, leaders may develop strategies for growth strategies in their 
customer base. 
In this study, I addressed AED market potential in the United States. I explored 
some medical device manufacturing and distribution marketing leaders’ marketing 
strategies to determine whether they are maximizing their customer base growth or 
leaving expansion opportunities in U.S. homes and public settings with unequipped AED 
programs. Given the facts on the consumer AED void and SCA statistics, further research 
of marketing strategies is recommended by this researcher. Further research is 
recommended to also explore the probability of influencing some AED manufacturing 
company leaders to recognize the value-add of an open business model, which stimulates 
innovation that may contribute to the prevention of SCD. Last, I recommend that AED 
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manufacturers and its distribution channels are made accountable in being responsive to 
answering questions that address why current methods of the prevention of SCD continue 
to fail. 
Presentation of the Findings 
In this section, I present the outcomes from the six interviews conducted. I 
provided the results from each of the questions presented to the participants. Each 
response is marked by an X for participants who responded to the respective question 
(Taylor, Bogdan, & DeVault, 2015), with a +1 to +3 agreement level where +3 is greatest 
agreement level and +1 being the lowest agreement level, as well as elaborated on the 
topic accordingly as illustrated in Appendix E. Participants who chose not to respond or 
disagreed with the question are marked 0 with a -1 to -3 disagreement level where -3 is 
the greatest disagreement level and -1 is the lowest disagreement level, and elaborated on 
the topic accordingly. I calculated an average score and noted it at the bottom of each 
question. Interpretation of the findings for each question is noted at the bottom of each 
table. A graph of the results for each question is provided to illustrate the results in visual 
form (see Appendix E).  
Interpretation of Findings 
 The themes that emerged from the data collected are strategies, and yield 
professionals use while addressing the problem. The themes/strategies and supporting 
data included: strategic marketing information security, dealing with regulatory 
constraints, and commercial versus consumer focus. 
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Strategy 1: Strategic Marketing Information Security 
A common concern for the security of strategic marketing was evident across the 
AED manufacturer participants with reluctance to discuss business models and marketing 
plans. During the interview and data collection, senior marketing leaders expressed their 
concerns regarding releasing any information. Strategic marketing information regarding 
the consumer market was an area AED manufacturers did not directly lead or influence 
and was left up to each individual distributor’s business model. Scores in Appendix E 
illustrate low or negative O scores by AED manufacturer participants related to engaging 
in partnerships; receptive to open business models; and the topic of sharing marketing 
strategies with others in the industry. In contrast, participants from their distributor 
network scored high or positive X scores in the same topic area. 
Strategy 2: Dealing with Regulatory Constraints 
The United States FDA has limited the number of approved AED manufacturers 
making the available sample of participants limited. The U.S. market is one of the largest 
in the world while AED manufacturers are mostly founded and originally established 
overseas. Manufacturers, which are approved by the FDA, must comply with their 
regulations and undergo frequent compliance reviews such as submitting premarket 
approval applications (PMAs). These applications require AED manufacturers to undergo 
a more rigorous review than what was required to market the medical devices in the past. 
Per participants during the interviews, the FDA’s reasoning for PMAs is to strengthened 
compliance reviews focused on the critical requirements needed to ensure the safety and 
reliability of AEDs and their necessary accessories. However, the effect of exacerbated 
  
80
regulatory compliance, while important from a safety aspect, curtails AED manufacturers 
limiting their innovation and marketing strategies. The potential of new products for the 
consumer market in the distribution channels is directly correlated to federal and 
regulatory sanctions.  
Strategy 3: Commercial vs. Consumer Market Focus 
Another common theme noted from AED manufacturer participants was their 
delineation from the consumer as opposed to commercial product demands. During the 
research, participants were not familiar with this shift in the healthcare industry and its 
effects on the consumer or aging market. Consumer service and medical responsiveness 
are considered by the AED manufacturers as an aftermarket outcome, however, 
distributor partnerships and local community programs are effective. First responders and 
hospital emergency units rely on trained CPR and AED bystanders. AED Manufacturers 
have developed solutions in telemedicine but lack innovation in emerging markets being 
developed by their partner network. 
AED manufacturers do not sell directly to consumers and rely on their distributor 
network for sales in this segment. This approach and perspective on the consumer market 
were shared by all AED manufacturers. In addition, AED manufacturers’ close business 
models and fear of IP loss curtail any opportunity for innovation in the consumer space.  
AED distributors are more engaged with technology and innovative business 
development opportunities to expand sales and market growth while servicing consumer 
needs. Participants from healthcare services and systems providers of medicine agree that 
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even though they do not control or influence AED pricing, they would participate as a 
conduit to prescribing the need of an AED for a patient at risk for SCA. 
Improving survival from SCA requires a system of care approach, and achieving 
Guidelines-level treatment for OOHCA requires significant effort across multiple 
healthcare segments. SCD prevention of healthy individual behaviors is not addressed in 
this study. AEDs are for the prevention of Sudden Cardia Death and do not prevent 
Sudden Cardiac Arrest. Participants from healthcare services and systems providers of 
medicine agree that comorbidities in the CVD population and the baby boomer increase 
in the elderly exceed sales growth of AEDs. Despite their agreement, sales in markets not 
supplying the demand and need of having an AED quickly accessible in the homes and 
public areas where the boomers spend their time, mortality statistics will continue to rise. 
Participants from the manufacturing companies did not agree to comment in this 
area in the protection of their competitive marketing strategy or unfavorable to expand on 
their responses. Participants from distribution networks representing manufactured 
products agreed to comment and favorable towards an open business model which 
promoted innovation and new business opportunities. Participants from healthcare 
services and systems providers concurred that affiliations and partnerships were 
necessary when a knowledge, skillset, or resource is required and not possessed 
internally, to fulfill their business mission statement.  
AED manufacturers support current publications showing evidence that there are 
limitations in having an AED at home. Affordability varies within the consumer market, 
yet boomers of less financial resources, look to insurance companies for support. 
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Consumers lack information and training in the use of an AED and thus uncertain in how 
or when to use it if they decide to own a home unit. In the home, AED monitoring 
solutions for prevention are emerging. Distributors are taking the initiative to create their 
own marketing strategies and look to their respective manufacturers to develop products 
that serve and accommodate the consumer market. 
Participants from healthcare services and systems providers concurred that while 
it may be 15 to 20 years from having an AED in every home, they also agree that it is 
imperative for an AED to be readily accessible in every home. AED training and 
informing potential bystanders in the home is an area healthcare service and systems 
providers agree that it can be easily achieved. AED Bystander training programs lack in 
the total solution for an effective response to SCA and preventing SCD. This issue is left 
to First Responders and the distributor networks’ business model of value-add solutions. 
Automated External Defibrillator distributors have adopted a new paradigm to address 
this market gap. AED Bystander training programs lack in the total solution for an 
effective response to SCA and preventing SCD. This issue is left to First Responders. 
Few AED distributors have adopted a new paradigm for address this market gap 
responders and the distributor networks’ business model of value add solutions.  
Only one of the two participating U.S. AED manufacturer is involved and 
approved to treat post-SCA patients using their medical devices and systems. The other 
U.S. AED manufacturer not involved in medical devices and systems supporting post-
SCA hospital solutions was primarily because of technology development cost and 
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stringent regulation by the FDA. Complete recovery for SCA victims includes post SCA 
treatment by medical devices and systems. 
Conclusions 
 The diversity in skill sets within the participants provided quality data from which 
to draw objective conclusions. These participants represented the top three AED 
manufacturers in the United States, North America, and the world. Participants shared 
similar perspectives in their responses. When compared to the distributors representing 
their respective AED product line, their perspectives differed in marketing strategies and 
market growth potential. For example, some distributors are focused on direct sales by 
way of the Internet and partnerships. Other distributors have non-profit mission 
statements are engaged in the direct delivery of the end-user as well as AED bystander 
training. When compared with the leaders in the medical community, their perspective on 
the AED manufacturers and distributors widely differ and question their direction away 
from the consumer demand and need.   
 The first conclusion with the AED manufacturer interviewees was their reluctance 
to engage in an open business model discussion. Their lack or limited response regarding 
this topic is primarily due to a business culture of protecting their intellectual property 
(IP) and fear of their information getting to competitors. Other reasons included their 
current compliance engagement from the U.S. Food and Drug Administration knows as 
premarket approval application (PMA), which was set forth in 2015. The regulatory 
challenge they face is FDA’s 2015 initiative (USFDA, 2015) for the approval of their 
compliance stipulated for AEDs.  
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 The PMA initiative is concerned with the FDA’s issue of a final order requiring 
AED manufacturers to submit premarket approval applications (PMAs). As participants 
of this rigorous review, all AED manufacturers in the United States are cautious about 
providing internal marketing strategies other than those published for public knowledge. 
Whatever the underlining reason may have been, it was evident that each AED 
manufacturer chose to limit the information and remain within their respective business 
models. The participant interviews, alongside the use of the questionnaire, invoked 
discussion as to why there are no concentrated strategies for the home AED unit where 
most of SCA incidents are occurring. 
 Another conclusion is that AED manufacturers marketing strategies are more 
focused on the commercial market and less on the consumer market, allowing their 
market penetration onto the larger commercial accounts to influence smaller consumer 
accounts. Their respective distributors have the autonomy to plan and execute on their 
own marketing and sales strategies. If respective distributors adhere to and follow the 
guidelines set forth in their distributors’ agreement, AED manufacturers allow them to 
execute their individual marketing and sales plans. Since each distributor falls in a sales 
volume tier, manufacturers concentrate their own sales in the commercial space. 
 A conclusion is that AED manufacturers have no significant focus on a home 
AED solution and yet the one manufacturer of a home AED unit with FDA approval, in 
this sample of participants, has established a consumer division along with a large tiered 
distributor channel. However, other than their FDA-approved home AED unit for sale 
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through distributors, their product line, and marketing is more concentrated on home 
monitoring units for the elderly and home-bound markets.   
Outcomes 
 Because the timing of the interviews, cooperating partners were involved in an 
FDA initiative strengthening its review to help improve the quality and reliability of the 
automated external defibrillator (USFDA, 2015). The outcome with AED manufacturers 
included limited access to strategic marketing management as well as being receptive in 
engaging themselves with this doctoral study. Time was limited and value-add to their 
involvement was questioned, respectively. Outcomes of their marketing strategies 
delineated from the consumer market, distributor network, and distributor network-only 
models engaging partnerships in innovation. 
 Unlike the AED manufacturers, AED distributors focused on the consumer 
market and were receptive to an open business model and partnerships. However, their 
marketing strategies and sales channels are ubiquitous in nature. Larger for-profit 
distributors’ sales are via the Internet, while some non-profit distributed provide AEDs at 
no cost to the consumer, as well as a bystander and CPR training.  
 Leaders from the medical community engaged in various medical rendering 
capacities in the field of CVD and SCD question the validity and purpose behind AED 
manufacturers’ marketing and sales strategies. Moreover, they question their lack of 
focus in markets where SCA occur the most and innovation would be best served. While 
they do understand the scrutiny in which the FDA governs their end products, they 
remain skeptical of the AED price tag per unit. Medical professional disagree with the 
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cost of the AED products despite the regulatory challenges they face with FDA’s 2015 
premarket approval application (PMA) initiative (USFDA, 2015). The PMA initiative has 
to do with the FDA’s issue of a final order requiring AED manufacturers to submit 
premarket approval applications (PMAs). The application forces AED manufacturers to 
undergo a rigorous review. This review has far more rigor that has been required of the 
AED manufacturers before marketing these devices in the past. The initiative itself is 
questioned by the medical leaders of its real motive behind FDA’s rigor. 
 Outcomes of practicing a close business model were evident within the medical 
device and AED manufacturers. None of the participants working for the leading U.S. 
companies manufacturing AEDs were transparent in discussing their plans for product 
development or emerging markets. Their partnerships did not include innovation or 
integration to their existing product lines. 
 Outcomes from the interviews with participants representing AED distributor 
channels did provide proof positive of engaging in partnership for product development 
and innovation. This was specifically evident with distributors in for-profit business 
models. However, many of the partnerships uncovered focused on further sales 
distribution and community-based initiatives. Distribution and sales to sub-distributors 
were identified, primarily in the retail arena among large pharmacy chain stores as well 
as Internet sales. None of the sub-distributors were engaged in solutions involving CPR 
or bystander training. 
 One large distributor and participant that was engaged as a non-profit company 
providing AEDs in school sports for young adults, did have both an open business model 
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and servicing its market with a total solution. The solution involved providing AEDs to 
high school sports programs ensuring the safety of young athletes during sports events. 
The athletic department included CPR and AED bystander training to all coaches and 
administrative personnel. 
Outcomes for consideration of further study regarding medical practitioners’ 
perspective on CVD, is a potential need. Participants from healthcare services and 
systems providers of medicine agree that comorbidities in the CVD population and the 
baby boomer increase in the elderly, and that they may be exceeding sales and growth of 
AED markets.  However, research in the study and current statistics continue to provide 
proof that over 88% of all SCAs are occurring at home and other remote areas. Thus, the 
assumptions stated before research are consistent with the finding. The question of CVD 
outnumbering AEDs may be less valid than that of the number of AEDs lacking 
marketing sales strategies in the market segments of need. 
The data collected and its findings were part of the conceptual framework for 
this study with the product life cycle (PLC) theory as a continuum.  The four life stages 
of a PLC in which a product passes through were evident during data collection from the 
participants. The product introduction cycle, including development and design 
compliance, was and continues to be an area of accountability which only the AED 
manufacturer own. Product growth, from a development and marketing perspective, was 
and continues to be a shared cycle of accountability by both the AED manufacturer and 
their respective distributors.  The maturity life cycle of the AED was evident from the 
distributor participants, during the data collection, as distributors resell the product down 
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in tiers as far as the retailer. The maturity of market, price, and technology. The AED 
product decline, which distinctively shares more market characteristics with other 
products in the same stage than with itself at a previous or later stage, occurs in the shelf 
life of the distributors and retailers. As a vital life-saving product, having a maximum 
shelf-life of five years, the AED declines in reliability and technology. During data 
collection, it was noted that while the product declined over time, pricing was held by 
each tier of the distributor.  
As the AED product line was infused onto organizational marketing strategies, 
PLC did provide useful insight into competitive tactics, an alternate perspective on how 
to address issues of supply and demand. However, the variance in marketing strategies 
from the manufacturer to the tiered distributors, yield different outcome to the respective 
organizations. Since it is people which manage organizations, their influence and the 
decision-making culture they created come from their behaviors. These decision-making 
cultures and behaviors noted in the participants, during the interviews, influenced their 
marketing strategies. 
The problem-solving process for medical device manufacturers in the United 
States was noted to have a dominant approach by its marketing leaders to PLC. However, 
once the AED product was sold to master distributors and in turn master distributors to 
sub-distributors, manufacturers lost their dominance with marketing strategies. This was 
a pivotal and important finding during the exploratory and interview phase of the data 
collection. As one manufacturing marketing leader stated, “we do not sell directly to our 
consumer and only to our distributors. What they decide regarding marketing is their 
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decision as long as they are compliant with the manufacturer-distributor agreement”. In 
losing their dominance, manufacturers could not longer contribute to growing their 
consumer customer base. In terms of the consumer market and its need to be supplied 
with AEDs in critical segments, manufacturer marketing strategy dominance and 
influence was lost.  
Other findings and potential connection to the literature review from the data 
collected were noted during the exploratory process. The first and foremost was the 
connection of the data collected in contrast with the business marketing management 
recommendations from scholars in this field. The delineation in marketing strategies 
between the manufacturers and its distributors clearly showed disconnect and loss of 
opportunities in the consumer space. In terms of the healthcare and retirement trends of 
the aging boomer with the specific dependency of accessibility and immediate medical 
attention in rural areas, the manufacturer did not entertain the topic nor were they concern 
for these trends. While distributors to some extent are selling ubiquitously across markets 
and servicing the boomer, they have no specific strategy towards the consumer segment 
of the market. The same results were found in emerging technologies, safety, governance 
and bystander training. During the data collection and interview process, one distributor 
described the AED and its consumer market as “a commodity with little chance of being 
purchased by homeowners, just look at all the publications.” Despite scholarly review 
and widespread information on this topic along with the knowledge that 88% of SCAs 
happen at home and public areas, data collected illustrates that there is no immediate 
change in marketing strategies by AED manufacturers their respective distributors. The 
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most receptive participants to the open business model and collaborative conversation 
regarding innovative marketing strategies were the healthcare professionals.  
In conclusion, while the PLC may augment open business models, manufacturers 
are losing their dominance through both, PLC shortcomings, close business models, and 
marketing strategies in the consumer space. Additional losses include the curtailment of 
outside ideas and technologies to be infused and propagate onto their products and 
services. This lack of infusion has reduced AED manufacturers’ their economic potential 
(Chesbrough, 2012), curtailment in their business growth and social responsibilities. 
Applications to Professional Practice 
The purpose of this multicase study was to explore the marketing strategies 
medical device manufacturing company leaders use to expand their consumer customer 
base. The results were inconsistent with the initial purpose. However until initial contact 
was made with the marketing manufacturers’ leaders, it would have been impossible to 
uncover at an earlier stage. Medical device manufacturing company leaders were 
reluctant to discuss their marketing strategies in detail and pivoted strategic marketing for 
their consumer products to their distributor network. Their marketing strategies are to 
focus on commercial products serving the demand of their larger customer base and 
building their brand. Thus their strategy in label branding and product sales of medical 
devices will proliferate onto their consumer product sales, such as the AED, through their 
distributor network. 
Making a shift towards the distributor network and healthcare professionals 
accommodated the study since focus remained in the consumer space. Although the 
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distributor network and healthcare entrepreneurs contributed to the study, it was also 
evident their strategic solutions specific to the home AED unit sales included a different 
strategic paradigm. Their paradigm included turnkey solutions for telemedicine; 
emergency responds systems, as well as the prevention of sudden cardiac death. 
Therefore, lobbying for regulation to expand their products to the home and public 
segments of the market, which remain without an AED, should be a consideration for 
action.  
Based on peer-reviewed literature and SCD statistics from the AHA, distributors’ 
partnerships should include organization focused on solving for boomer demand and 
healthcare solutions for the prevention of SCD by integrating their ideas and 
technologies. Healthcare entrepreneurs should be a challenge in launching for-profit and 
non-profit corporations with the mission to prevent SCD. These corporations would have 
the required strategic vision, robust resource, and limited regulatory requirements to 
invoke their solutions in the U.S. markets and beyond. The dissemination of these results 
would ensure the aging population of boomers’ protection and prevention of SCD 
worldwide. Also Based on participant’s comments from the AED manufacturer regarding 
their marketing only on the commercial and not on the consumer market, it is clear that 
marketing leaders need to re-think their marketing strategies. 
The results of this study will be beneficial if these proposed applications for 
business practice, in the consumer market space with an emphasis on the boomer, are 
considered as critical objectives for more effective outcomes in regard to product 
affordability; home AED target marketing; decrease in healthcare expense; and reduction 
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of SCDs. In addition, by disseminating the findings and recommendations of this study 
through publications and presentation of its results in professional conferences, 
legislative session, and professional workshops, they will also yield effective outcomes. 
The entire study will be published in the ProQuest/UMI dissertation database. As the 
researcher, I also plan to publish parts of the study in several scholarly articles for other 
aspiring entrepreneurs to further the study. 
Implications for Social Change 
As part of social change, the procurement and placement of AEDs may prevent 
the loss of the lives to some of the 350,000 SCA victims dying annually of which 88%, or 
more than 308,000, are occurring at home and public settings (AHA, 2013). This 
qualitative case study and its design contributed toward a proposed solution for the 
business problem. Residual outcomes included opportunities to make an additional 
positive social change.  
The outcomes derived from this research contributed to further motivate medical 
device manufacturing and distribution marketing leaders to infuse positive changes. 
Some changes may include influencing AED manufacturers, distributors, and medical 
entities to adopt an open business model to further increase revenue in sales and service; 
augment retail partners; infuse innovation in distribution channels, and gain a competitive 
edge in the consumer goods space. Residual outcomes for social change may contribute 
to improving the quality of life for the aging population while reducing the loss of the 
lives of 350,000 SCA victims dying annually (AHA, 2013). In reducing the loss of lives, 
it may help reduce costs of approximately $100 billion in annual expense (Heidenreich et 
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al., 2011) for the United States alone. The purpose was to explore their ability to 
contribute to the development of a new customer base in the AED marketplace. By 
exploring their plans for expanding public, consumer, and private accessibility, an 
expectation of remodeling their business remains as part of a contribution to social 
change. 
Previous studies in this space, such as Pruchno (2012) and Rashidi & Mihailidis 
(2011), have not included the aging population entering retirement as an emerging 
market. Although the foundation is established in which to develop marketing strategies, 
no content is found on the topic. Yet, the large number of aging baby boomers retiring 
and moving to remote areas without in-home AEDs is the greatest gaps in the consumer 
market (Heidenreich et al., 2011). The literature review for this study premises other 
issues and potential marketing opportunities that are part of this review. The inclusion is 
specific to the dependency of accessibility and immediate medical attention and its 
relation to AEDs with the knowledge that 88% of SCAs happen at home and public areas. 
Solving for this dilemma would save the lives of the boomers; improve the changes of 
quality of life for survivors, and reduce healthcare cost in the hundreds of millions of 
dollars. 
Recommendations for Action 
Because of the findings stated in this study, I have several recommendations for 
action. The recommendations are stated below in the order of priority. Each 
recommendation includes specific and useful actions, as well as the identification of 
those entities needing to act. 
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Manufacturer marketing managers were the most difficult and least willing to 
cooperate with this study. Their reluctance included concerns in disavowing critical 
product and marketing information, which could be passed on to their competitors or 
regulators. This mindset was also prevalent and noted during any discussion or questions 
regarding the open business model. Their response pivoted to their distributor network as 
the entity of choice for this topic.  
Other reluctance to collaborate and give their time included a need for a returned 
on investment for their contribution of information and time. Despite the fact, they work 
in a highly-regulated sector with the medical device manufacturing community, resolving 
serious product development and social issues, collaboration, and transparency will yield 
a space of innovation and marketing opportunity. Thus, my recommendation is to 
overcome AED manufacturers’ close business models by way of lobbying for regulation 
to expand their products to the home and public segments of the market that remain 
without an AED. The dissemination of these results would ensure the aging population of 
boomers’ protection and prevention of SCD. 
AED Distributor marketing managers were the most receptive to an open business 
model and recipients of its value-add to their market growth. Distributors’ business 
models varied with two distinct attributes and market focus. The first were those engaged 
in commodity and retail sales with the available product online or on the shelf where the 
market demand is filled by an as needed basis. This model has no proactive marketing 
and advertising model reaching the aging and boomer population nor homeowner. It has 
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no foundation for a proactive and preventive marketing strategy towards market growth 
and prevention of SCD.  
For this type of distributor, my recommendation is for them to invest in marketing 
and advertising campaigns reaching the said market segment. In addition, I recommended 
that their partnerships include organization focused on solving for boomer demand and 
healthcare solutions for the prevention of SCD. The dissemination of these results would 
ensure the aging population of boomers’ protection and prevention of SCD. The second 
type of distributor is classified as an integrator. 
The integrator-type distributor is one engaged with an innovative approach to a 
complete solution. Their attributes include an open business model where both 
technologies in product development and marketing strategy solve the business problem 
and meet its social responsibility. While having both business model and attributes, 
which yield an opportunity for solutions development for the home and public areas, their 
focus is on the commercial segment of the market versus the consumer space. My 
recommendation is to develop strategies to solve for these market growth opportunities 
and move ahead of any potential future legislature mandating solutions by way of 
compliance. The dissemination of these results and proactive marketing strategies would 
ensure the aging population of boomers’ protection and prevention of SCD. 
Healthcare professionals and the corporations they represented during the study 
were the most engaged and partaking in solution development with the objective of 
saving lives. Their approach to SCD included global ubiquity and problem solving for 
each respective international market and inclusive of the aging population and its 
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vulnerability of CVD. However, their limitations and ability to solve for the prevention of 
SCD are contingent on the manufacturers and distributors of medical devices such as the 
AED. Since this research has uncovered that healthcare professionals participating and 
cooperating with this study have the financial resources and attributes of 
entrepreneurship, my recommendation would be to challenge them in launching for-profit 
and non-profit corporations with the mission to prevent SCD. These corporations would 
have the required strategic vision, robust resources, and limited regulatory requirements 
to invoke their solutions in the U.S. markets and beyond. The dissemination of these 
results would ensure the aging population of boomers’ protection and prevention of SCD 
worldwide. 
Recommendations for Further Study 
The uniqueness of this study is that I addressed a business problem by way of new 
marketing strategies solving for market grown while directly contributing to a social issue 
that remains to be solved. Despite having the tools and resources to combat SCD, the 
United States is limited only by its entrepreneurial foresight and regulatory constraints. 
Future studies could explore a close examination of the strategies needed in lobbying 
regulatory entities to mandate for all new housing, existing homes, and public places to 
have an AED unit installed.  
 Further research in new AED technologies that reduce the cost of AED home 
units would contribute to the easing of access to a safe, reliable, and affordable product 
for the aging boomer and general population. Other recommendations of further studies 
include search-and-find mobile applications to locate AED positioning for immediate 
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access, as well as bystanders training during SCA in public areas. A larger sample and 
on-site interviews with medical device marketing managers would provide a greater 
opportunity to discuss the infusion of open business models and strategic partnerships. 
Future studies could include objectives towards social contribution in saving the lives of 
the more than 340,000 annual cases of SCD (AHA 2013) outside healthcare facilities. 
Inclusive in future studies, post-SCA medical equipment solutions to accelerate recovery 
and minimize loss of productivity at the workplace is highly recommended. 
As it relates to marketing strategies, further studies should have specificity in 
researching how medical device manufacturers could pursue and compete in all AED 
markets by adopting an open business model. Furthermore, that studies include 
opportunities in establishing global presence while leading in technical reliability and 
quality by leveraging redundancy, intelligence, and automation with the highest operating 
standards possible. Lastly, the research should explore how an increase in profitability 
and cash flow could be leveraged in providing product affordability for the aging baby 
boomers. 
Boomers will remain as the target market for medical devices such as the AED. 
However, boomers are living longer and working past age 65 which creates an 
opportunity for investments in products and services they will need upon retirement. 
Further study of the boomer and investment opportunities in products and services they 
will use or consume in the future are recommended. Boomers will continue to be an at-
risk aging population with large healthcare facilities across remote and suburban areas 
back to the metropolitan and inner city areas to minimize expenses. Further studies on 
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how to solve the vast amount of healthcare services needed for the aging boomers retiring 
in remote areas with less emergency response services and resources are recommended. 
Reflections 
I conducted this qualitative, multicase study to explore participants’ strategic 
thinking, business model paradigm, and forward-thinking marketing strategies. 
Moreover, I conducted the study to explore their experiences and perceptions on open 
business models and seeking external expertise for innovation and social contribution. 
The process exposed me to passionate and dynamic individuals dedicated to their mission 
and the fundamental factors motivating them to sustain market growth. I was very 
thankful for the exposure into this industry and impressed by the level of information 
sharing by participating distributors and healthcare professionals. Their passion for 
meeting the market demand and social needs epitomized a sincere accountability toward 
the prevention of SCD.  
As the researcher, I had preconceived ideas that the cooperating manufacturing 
companies would be receptive the purpose of my research. However what I experienced 
was a cautious and distant reception, filled with potential risk in conveying intellectual 
property and marketing strategies. In the same way, I approached my cooperating 
companies with an assumption that they would recognize the potential value in the 
research process. The experience was a total antithesis and had to resort to leveraging 
their accountability and social responsibility to this initiative.  
In contrast, the experience was considerably different with participants from the 
AED distribution network and healthcare professionals. They welcomed the value in 
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partnerships and collaborative engagement as a way for business growth and combating 
SCD. The effects of this researcher on the interface with participants throughout the 
interviews yield changes in my perspective toward the problem-solving paradigm of the 
study. 
Summary and Study Conclusions 
The study was conducted to solve a business problem. My initial perception was 
that by influencing medical device manufacturer marketing managers to infuse an open 
business model, the existing paradigm would be changed. The change was expected to 
contribute towards new marketing strategies focused on the growth of the consumer 
market. The true outcomes, after the research, were considerably different.  
In this qualitative, multicase study, I used a questionnaire as the premise during 
the interviews with the participants. Thus, it provided considerable insight to AED 
manufacturer managers’ mindset and marketing perspectives towards the commercial and 
consumer markets. The data collected, analyzed, and illustrated, supported the conclusion 
that marketing manufacturer marketing strategies do not extend to the consumer market 
as they are in the commercial market. Also, findings indicated that AED manufacturers 
do not sell directly to the consumer nor are they involved with or influence the marketing 
strategies for their distributors. Furthermore, findings supported the notion that their 
reluctance to engaging in any such study outside their silo is indicative of their close 
business model and protection of product knowledge and new developments. On the 
other spectrum of this paradigm are the distributors and healthcare entrepreneurs 
immersed in growth initiatives and emerging mhealth technologies. While neither have a 
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specific focus on the total home unit solution or the baby boomer market, they practice an 
open business model receptive to new ideas and partnerships. 
Based on this study and previous research, I argue that a better business model, 
regulatory emphasis, and social responsibility, are needed for a better model to improve 
the reduction of sudden cardiac deaths. Therefore, this study demonstrates a need for 
further investigations on other factors that may possibly affect the development of new 
marketing strategies and regulatory mandates to improve AED performance, access, cost, 
and search-and-find technologies to grow the AED consumer market. 
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SUBJECT:  Request of Pseudo AED U.S., Inc. for Arturo Cervantes Doctoral Study  
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professionals currently working for Pseudo AED U.S., Inc. as part of a doctoral 
study. The Title of the study is Exploring Strategies for Expanding the U.S. 
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Pseudo AED U.S., Inc. is either endorsing or sponsoring this study. 
Furthermore, Pseudo AED U.S., Inc. will not assume any liability for the 
research under this study.  
 
2. The Principal Researcher for this study is Mr. Arturo Cervantes. 
 
a. Mr. Cervantes is a doctoral candidate in the school of Business and 
Technology at Walden University.   
 
b. Mr. Cervantes is the College President for Fortis College in Houston, 
Texas.   
 
c. Mr. Cervantes is currently working on a qualitative case study exploring 
strategies for expanding the U.S. Automated External Defibrillator Market 
with a social contribution in preventing sudden cardiac deaths (SCD) in 
the United States. 
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d. Mr. Cervantes’ doctoral study intent is to identify and collect the most 
valued and relevant elements in the marketing, sales, and distribution of 
the AED to the consumer market. 
 
e. Dr. Michael Ewald, of the Walden University’s College of Management & 
Technology DBA Program, will be the contributing faculty supervising 
this research. 
 
3. This is a request for cooperation to allow members of Pseudo AED U.S., Inc., to 
engage in interviews to provide their perceived insight and knowledge.   
 
a. The participation in this interview is voluntary. Participants meeting the 
criteria and electing to participate in this interview not only will have the 
option to decline to participate without penalty; they will have the option 
to abandon the interview at any time during the interview process.  
 
b. There will be no incentives or rewards offered for participating in the 
interview.  
 
c. Mr. Cervantes designed the questions to gather the knowledge and 
experience of the participants on business performance and model, product 
distribution, product affordability, strategies for expanding consumer 
markets, and contribution to minimizing SCD. 
 
d. All data collected will be from public operations and execution processes 
related to the experience and knowledge of the participants. 
 
e. The interview will entail ten open-ended questions related to strategies in 
expanding the AED consumer market. 
 
f. Mr. Cervantes request interviewing the participants as means of verifying 
the responses to the interview questions. 
 
g. To verify Mr. Cervantes’ interpretations of the interviews maintained the 
integrity of their responses and his inferences accurately express the 
participants’ opinions, Mr. Cervantes may schedule a follow-up member-
checking without any new questions with participants as a means of 
verifying information and validity only if needed.  
 
h. Mr. Cervantes will verify the accuracy of the transcript by allowing the 
participant to have the opportunity to amend, modify, expand, or clarify 
any of his or her original responses.   
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4. Mr. Cervantes will protect the rights and welfare of Pseudo AED U.S. Inc., and 
its participants by applying the following provisions.  
 
a. Only Mr. Cervantes, and his doctoral committee (Dr. Michael Ewald, Dr. 
Kelly Chermack, and Dr. Judith Blando), and authorized Walden 
personnel will have access to the study’s data. 
 
b. Mr. Cervantes will not use the participant responses outside the scope of 
his research. 
 
c. Mr. Cervantes will edit all responses to remove any information 
describing specific information about Pseudo AED U.S., Inc., its 
subordinate units, its higher command, or information readers can use to 
identify the selected participants.   
 
d. Mr. Cervantes will code all participants’ names, remove company name 
from marketing documentation, and perform all data analysis and 
conclusion based solely on this data code in order to protect the identity of 
the participants. 
 
e. Mr. Cervantes intends to conduct all interviews over the phone.  
 
5. Mr. Cervantes does not have any influence or connections with Pseudo AED 
U.S., Inc., or its employees eliminating potential conflict of interest concerns.   
 
6. The point of contact is the undersigned. 
 
 
Arturo Cervantes                ___________ 
 
Arturo Cervantes, MBA    Pseudo AED Signee 
DBA Candidate      Public Information Officer 
Technology Entrepreneurship    Pseudo AED U.S., Inc.  
College of Management & Technology 
Walden University 
Email: arturo.cervantes@waldenu.edu 
Mobile: (210) 569-4134 
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Appendix B: Interview Protocol and Questions 
Interviewee Name: ___________________________________ 
Interview No: ______________           Date: _______________ 
Introduction: 
Before we begin the interview, I would like to take this time to discuss and explain the 
consent document before you. After explaining this document, I will be asking for your 
signature to indicate that you are willing to participate in the study and this interview.  
Thank you for agreeing to this interview. (Go through the informed consent of the 
participant). 
After obtaining signature: 
As indicated in the inform consent document this interview will be recorded. (Start the 
tape recorder). 
Interview Questions 
1. Would you describe how your company’s business model is open to 
partnerships that promote innovation? 
2. How does the U.S. automated defibrillator market compare to others in the 
world? 
3. How has your AED distributor network model evolved over the last few 
years? 
4. How far are we from having an AED in every home? 
5. How will first responder services be affected in case of SCA with 
hospitals moving from rural to metropolitan areas? 
6. How is product affordability of AEDs for the aging senior consumer being 
addressed by your company? 
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7. Would you describe your company’s perspective of AED Training 
Programs as a product value-add for market growth?  
8. How have AED recalls influenced your product design? 
9. Despite public awareness of CVD and large market share of AED sales in 
the United States, why does CVD still account for over 340,000 deaths 
outside of healthcare settings each year? 
10.  Would you elaborate on your company’s involvement in medical device 
solutions for hospital treatment post-SCA? 
Post Interview Comments: 
Thank you for participating in this interview.  
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Appendix C: National Institutes of Health Training Certificate 
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Appendix D: Tables of Interpretation of Findings 
Table D1 
Strategies and Themes for S1 
S1: How Open to Partnerships Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Are very open and innovation-centric with the 
potential to innovate yet protective of 
intellectual property (IP) 
0-3 O-2 X+3 X+2 X+1 X+1 
Lead with industry’s technical knowledge by 
exploiting external resources for knowledge 
base 
0-3 0-2 X+3 X+3 X+1 X+2 
Need a paradigm change in capability to 
transform the business for new growth 
opportunities 
 
0-3 0-2 X+3 0-1 X+1 0-1 
Average Score -3 -2 +3 +2 +1 +1 
Interpretation of the findings: 
• Interviewers from the manufacturing 
companies did not agree to comment 
in this area in protection of their 
competitive marketing strategy or 
unfavorable to expand on their 
responses 
• Interviewers from distribution 
networks representing manufactured 
products agreed to comment and 
favorable towards an open business 
model which promoted innovation 
and new business opportunities 
• Interviewers from healthcare services 
and systems providers concurred that 
affiliations and partnerships were 
necessary when a knowledge, skillset, 
or resource is required and not 
possessed internally, to fulfill their 
business mission statement  
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Figure D1. S1 response chart. 
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Table D2 
Strategies and Themes for S2 
S2: Defibrillator Market Comparison U.S. to 
World 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
U.S.  to World dominance – FDA approved X+3 X+2 X+1 X+1 0-1 X+2 
Europe and Latin America next largest with 
growth potential 
X+2 X+3 X+1 X+1 0-1 X+3 
Asia and Pacific Realm smallest share with 
slow growth and concerns with IP breaches 
X+1 X+1 0-1 0-1 0-1 X+1 
Average Score +3 +3 +1 +1 -1 +3 
Interpretation of findings: 
• The United States FDA has limited 
the number of approved AED 
manufacturers 
• The U.S. market is one of the largest 
in the world while AED 
manufacturers’ are mostly founded 
and originally established overseas 
• The next largest market opportunity 
is with growth in Europe and Latin 
America, with Asia and the Pacific 
Realm following 
• Manufacturers remain concern with 
losing intellectual property (IP) in 
entering the Asia and Pacific Realm 
markets 
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Figure D2. S2 response chart. 
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Table D3 
Strategies and Themes for S3 
S3: Evolution of the Distributor Network 
Model 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Commercial networks traditionally have 
included more corporate oversight with less 
oversight on consumer distributors and remain 
that way today 
O-3 O-3 O-3 X+3 O-2 O-1 
Traditional models applied to commercial 
networks  and retail via Internet distributions 
are continuing to evolve within the distributor 
networks 
O-1 O-3 O-3 X+3 O-2 O-2 
General community use and First Responder 
use type products will remain with consumer 
distributors; Clinical use type products with 
corporate field sales force. No direct sales 
from manufacturers to consumer markets are 
expected in the future 
X+2 X+3 O-3 X+3 X+2 X+1 
Average Score -2 -3 -3 +3 -2 -2 
Interpretation of findings: 
• The United States FDA has limited 
the number of approved AED 
manufacturers 
• The U.S. market is one of the largest 
in the world while AED 
manufacturers are mostly founded 
and originally established overseas 
• The next largest market opportunity 
is with growth in Europe and Latin 
America, with Asia and the Pacific 
Realm following 
• Manufacturers remain concern with 
losing intellectual property (IP) in 
entering the Asia and Pacific Realm 
markets 
• Product utilization by the consumer 
reluctance remains in purchasing 
decisions 
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Figure D3. S3 response chart. 
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Table D4 
Themes and Strategies for S4 
S4: AED in every home forecast Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Consumer affordability and its use is volatile O-2 O-3 X+2 X+1 X+3 X+3 
Bystander reluctance of legal risks challenges 
in home and public areas of AED utilization 
X+2 X+3 X+2 X+3 O-3 O-3 
Home technology innovations in monitoring 
are emerging  
X+2 X+3 X+2 X-1 X+3 X+3 
Average Score +2 +3 +2 +3 +3 +3 
Interpretation of findings: 
• AED manufacturers support current 
publications showing evidence that 
there are limitations in having an 
AED at home 
• Affordability varies within the 
consumer market, yet boomers of less 
financial resources, look to insurance 
companies for support 
• Consumers lack information and 
training in the use of an AED and 
thus uncertain in how or when to use 
it if they decide to own a home unit 
• In-home AED monitoring solutions 
for prevention are emerging 
• Interviewers from healthcare services 
and systems providers concurred that 
while it may be 15 to 20 years from 
having an AED in every home, they 
also agree that it is imperative for an 
AED to be readily accessible in every 
home. AED training and informing 
potential bystanders in the home is an 
area healthcare service and systems 
providers agree that it can be easily 
achieved  
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Figure D4. S4 response chart. 
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Table D5 
Strategies and Themes for S5 
S5: Responder services effects on SCA 
associated with hospitals rural-to-metropolitan 
area transition 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Consumer demands for product will be 
serviced in accord with market shifts 
O-3 O-2 X+3 X+3 X+2 X+1 
First Responder services will continue to grow 
and adapt to consumer demands 
O-3 O-2 X+3 X+3 X+2 X+1 
Home technology innovations in monitoring 
will grow with this market shift as boomers 
are located further from first-responder 
services 
O-3 O-2 X+3 X+3 X+2 X+1 
Average Score -3 -2 +3 +3 +2 +1 
Interpretation of findings: 
• AED manufacturers are not familiar 
with this shift in the healthcare 
industry and its effects on the 
consumer or aging market 
• Consumer service and medical 
responsiveness is considered by the 
AED manufacturers as an aftermarket 
outcome, however, distributor 
partnerships and local community 
programs are effective 
• First responders and hospital 
emergency units rely on trained CPR 
and AED bystanders 
• AED Manufacturers have developed 
solutions in telemedicine but lack 
innovation in emerging markets being 
developed by their partner network 
• Interviewers from healthcare services 
and systems providers concurred that 
the responders time will increase and 
that later arrival times will decrease 
the patient’s chances of survival from 
SCA 
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Figure 5D. S5 response chart. 
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Table D6 
Strategies and Themes for S6 
S6: Product affordability of AEDs for the 
aging senior consumer 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Consumer market is indicating price is too 
high and needs lowering trends  
O-3 O-3 X+2 X+1 X+3 X+3 
Innovation and new product releases will 
influence lower pricing on existing models 
with respect to all segments of the 
consumer market 
O-1 O-1 X+3 X+2 X+3 X+3 
Partnerships from distribution channels are 
adapting their business models to address 
consumer needs 
X+1 X+2 X+2 X+3 O-3 O-3 
Average Score -3 -2 +2 +2 +3 +3 
Interpretation of findings: 
• AED manufacturers do not sell 
directly to consumers and rely on 
their distributor network for sales 
in this segment 
• AED manufacturers’ close 
business models and fear of IP loss 
curtail any opportunity for 
innovation in the consumer space 
• AED distributors are more 
engaged with technology and 
innovative business development 
opportunities to expand sales and 
market growth while servicing 
consumer needs 
• Interviewers from healthcare 
services and systems providers of 
medicine agree that despite the 
fact that they do not control or 
influence AED pricing, they would 
participate as a conduit to 
prescribing the need of an AED for 
a patient at risk for SCA 
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Figure D6. S6 response chart. 
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Table D7 
Strategies and Themes for S7 
S7: Describe your company’s perspective of 
AED Training Programs as a product value-
add for market growth 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
AED training solutions as a value add for 
AED manufacturer and its distributor network  
O-3 O-2 X+3 O-2 X+1 X+2 
Innovation and new product releases 
contribute to the ease of AED use reluctance 
O-3 O-2 X+3 X+1 X+3 X+3 
Partnerships from distribution channels are 
adapting their business models to address 
consumer needs 
O-3 O-2 X+3 O-1 X+2 X+2 
Average Score -3 -2 +3 -2 +2 +2 
Interpretation of findings: 
• AED Bystander training programs 
lack in the total solution for an 
effective response to SCA and 
preventing SCD 
• This issue is left to First Responders 
and the distributor networks’ 
business model of value add solutions 
• Few AED distributors have adopted a 
new paradigm to address this market 
gap 
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Figure D7. S7 response chart. 
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Table D8 
Strategies and Themes for S8 
S8: AED recalls influence on your product 
design 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
AEDs sold in the U.S. must be Class III 
approved  
X+3 X+3 O-1 X+2 X+1 X+1 
Products from 2012 to present have overcome 
past deficiencies in being unable to deliver 
needed defibrillator shock in a cardiac 
emergency situation, yet the FDA remains 
with rigorous enforcement of its policies and 
oversight through PMA 
X+2 X+3 O-1 X+3 X+2 X+2 
Manufacturer’s self-initiate voluntary medical 
device recalls of its AEDs to ensure reliability 
and performance 
X+2 X+3 O-1 X-3 O-1 O-1 
Average Score +2 +3 O-1 +2 +1 +1 
Interpretation of findings: 
• AED Bystander training programs 
lack in the total solution for an 
effective response to SCA and 
preventing SCD 
• This issue is left to First Responders 
and the distributor networks’ 
business model of value add solutions 
• Few AED distributors have adopted a 
new paradigm for address this market 
gap 
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Figure D8. S8 response chart. 
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Table D9 
Strategies and Themes for S9 
S9: CVD still account for over 340,000 deaths 
in the United States outside of healthcare 
settings each year despite volume sales 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Heart disease remains prevalent in this country 
due to eating habits; lack of exercise; and 
tobacco smoking 
X+1 X+2 X+1 X+1 X+3 X+3 
Sudden Cardiac Arrest is both result of poor 
living behaviors and genetics 
X+3 X+3 X+1 X+1 X+2 X+2 
OOHCA Guidelines / System of Care 
obstacles exist 
X+3 X+2 X+1 O-1 O-2 O-2 
Average Score +2 +2 +1 +1 +2 +2 
Interpretation of findings: 
• Improving survival from SCA 
requires a system of care approach, 
and achieving Guidelines-level 
treatment for OOHCA requires 
significant effort across multiple 
healthcare segments 
• SCD prevention of healthy individual 
behaviors are not addressed in this 
study 
• AEDs are for the prevention of 
Sudden Cardia Death and do not 
prevent Sudden Cardiac Arrest 
• Interviewers from healthcare services 
and systems providers of medicine 
agree that comorbidities in the CVD 
population and the baby boomer 
increase in the elderly exceeds sales 
and growth of AEDs  
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Figure D9. S9 response chart. 
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Table D10 
Strategies and Themes for S10 
S10: Role your company plays in medical 
device solutions for hospital treatment post-
SCA 
Inter1m Inter2m Inter3d Inter4d Inter5h Inter6h 
Ventricular fibrillation (a rapid quivering of 
the main pumping chambers in the bottom of 
the heart) called the ventricles occurring in 
SCA, is treated by other medical devices post-
defibrillation 
O-3 X+3 X+3 X+3 X+3 X+1 
Past heart attacks leave scar tissue that 
changes the electrical patterns of the heart. 
This risk factor is treated by other medical 
devices manufactured by our company 
O-3 X+1 O-3 O-3 O-2 O-2 
Genetic disorders that cause subtle changes in 
the heart rhythm are medical treatment and 
surgically implanted versions for patients at 
high risk 
O-3 X+2 O-3 O-3 O-3 O-1 
Average Score -3 +2 -3 -3 -2 -1 
Interpretation of findings: 
• Only one U.S. AED manufacturer is 
involved and approved to treat post-
SCA patients using their medical 
devices and systems 
• Less U.S. AED manufacturers are in 
the medical devices and systems 
supporting post-SCA hospital 
solutions 
• Complete recovery for SCA victims 
includes post SCA treatment by 
medical devices and systems 
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Figure D10. S10 response chart. 
 
